https://www.pharmaceutical-technology.com/comment/commenthemophilia-gene-therapies-impress-but-pricing-doubts-remain-5873756/ 2017-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehealth-and-wealth-the-ten-biggest-pharmaceutical-companies-by-revenue-4944534/ 2021-10-29T08:05:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureus-drug-imports-a-recipe-for-disaster-5852374/ 2017-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-biotechs-tremfya-gets-fda-approval-for-plaque-psoriasis-treatment-5870823/ 2017-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsemergent-biosolutions-to-buy-sanofis-smallpox-vaccine-business-for-125m-5872031/ 2017-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-pfizers-snda-for-xeljanz-to-treat-ulcerative-colitis-5872500/ 2017-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-north-china-pharmaceutical-arena-pharmaceuticals-enterome-bioscience-5869363/ 2017-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-sanofi-ge-healthcare-medicure-5869372/ 2017-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbnf-and-bnfc-launch-new-app-for-health-and-social-care-professionals-5870236/ 2017-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-recommends-approval-for-novartis-ctl019-to-treat-rr-b-cell-all-5870257/ 2017-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-validates-gilead-sciences-marketing-application-for-bicftctaf-combination-5870775/ 2017-07-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretreating-mononucleosis-why-the-mystery-5688881/ 2020-01-31T13:43:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-invest-more-100m-to-expand-sydney-manufacturing-plant-5868909/ 2017-07-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newserytech-queens-university-collaborate-for-arginase-1-deficiency-treatment-5869176/ 2017-07-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-report-shows-decrease-in-apps-launched-by-pharmaceutical-companies-5869568/ 2017-07-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabzena-and-obi-pharma-sign-licence-deal-for-thiobridge-technology-5868206/ 2017-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-agrees-to-buy-protein-sciences-for-750m-5868216/ 2017-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-max-planck-and-lead-discovery-collaborate-to-develop-new-cancer-treatment-5868315/ 2017-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdeclining-trend-in-japanese-clinical-trials-5867735/ 2017-10-26T11:40:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportwill-orencia-be-able-to-compete-in-an-already-crowded-market-5867543/ 2017-07-11T07:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-spread-of-counterfeit-pharmaceuticals-across-the-middle-east-poses-threats-for-pharma-html/ 2021-11-02T03:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsignytas-cancer-drug-entrectinib-gets-fda-orphan-drug-status-5866892/ 2017-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-emmaus-endari-to-treat-sickle-cell-disease-5866958/ 2017-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrace-and-targimmune-to-develop-new-cancer-therapies-5867332/ 2017-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnestling-in-food-giant-makes-its-mark-on-the-healthcare-industry-5867730/ 2017-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurereforming-paediatric-cancer-trials-in-europe-5852474/ 2017-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-submits-ind-application-for-shp654-to-treat-haemophilia-a-5863952/ 2017-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-bristol-myers-squibbs-orencia-for-psoriatic-arthritis-treatment-5864212/ 2017-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsg-ba-confirms-tevas-cinqaero-gives-minor-additional-benefit-in-severe-asthma-5866104/ 2017-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-heart-failure-market-set-to-cross-16bn-by-2026-5860943/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-valeant-pharmaceuticals-international-immunoprecise-antibodies-5862645/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-acino-pharma-oriola-kd-corporation-immunoprecise-antibodies-5862657/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-wider-use-of-alexions-strensiq-for-hypophosphatasia-treatment-5862828/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelgene-to-acquire-rights-to-beigenes-pd-1-inhibitor-for-solid-tumour-cancers-5862858/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmercks-keytruda-stumbles-in-multiple-myeloma-5865039/ 2017-07-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureimmuno-oncology-where-to-go-in-a-packed-field-5839060/ 2022-11-03T05:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsenglands-chief-medical-officer-highlights-need-for-better-access-to-genetic-testing-5862162/ 2017-07-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsneovacs-centurion-sign-license-agreement-for-lupus-treatment-ifnalpha-kinoid-in-turkey-5862562/ 2017-07-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-mrc-researchers-reveal-structures-of-tau-filaments-from-alzheimers-disease-5862827/ 2017-07-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejunes-top-stories-takeda-and-biological-e-collaborate-jj-completes-actelion-acquisition-5859602/ 2017-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-and-fda-propose-new-approach-for-gaucher-disease-drug-development-5860668/ 2017-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-and-incyte-receive-marketing-approval-for-ra-treatment-olumiant-in-japan-5860852/ 2017-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglenmark-secures-uk-mhra-approval-for-anti-malarial-medication-5861968/ 2017-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-pfizers-acute-lymphoblastic-leukemia-treatment-besponsa-5858899/ 2022-02-14T08:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-selects-third-oncology-target-in-discovery-partnership-with-immunocore-5859395/ 2017-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmitsubishi-tanabe-pharma-receives-approval-for-development-and-sale-of-canalia-tablets-in-japan-5860139/ 2021-10-27T12:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureroundtable-discussing-trends-in-contract-manufacturing-5819662/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-use-of-novartis-zykadia-in-alk-positive-nsclc-patients-5857768/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-completes-sale-of-dendreon-to-sanpower-for-8199m-5857948/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsipsen-and-saol-partner-to-co-promote-dysport-in-us-5858793/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportchlamydia-testing-one-step-back-but-two-steps-forward-5859443/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnon-industry-trials-were-more-frequent-than-industry-trials-in-2016-5859637/ 2017-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-polish-pharmaceutical-industry-set-to-reach-11bn-by-2021-5855932/ 2017-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrt-and-merck-extend-partnership-to-discover-new-cancer-drugs-5856299/ 2017-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsarrien-pharmaceuticals-signs-license-agreement-for-psoriasis-treatment-arn-6039-5856418/ 2017-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-repligen-laboratoire-aguettant-orig3n-5857325/ 2017-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsma-this-week-oxis-international-hangzhou-tianmushan-sinovac-biotech-5857337/ 2021-10-22T07:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportanalyst-forecasted-growth-of-battling-blockbusters-keytruda-and-opdivo-5858262/ 2017-06-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-roches-new-esbriet-tablet-formulation-for-ipf-5854157/ 2017-06-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-starts-construction-on-new-rd-facility-in-missouri-us-5854732/ 2017-06-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmithra-and-fuji-pharma-sign-deal-to-market-hormone-therapy-donesta-in-japan-and-asean-5855745/ 2021-11-22T13:05:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfdas-new-price-tackling-strategy-puts-pressure-on-the-pharmaceutical-industry-5856681/ 2017-06-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovel-approaches-to-us-cancer-research-funding-on-the-horizon-5856685/ 2017-06-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentsamsung-bioepis-emerging-as-strong-player-in-the-autoimmune-space-5855125/ 2017-06-28T08:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-designation-to-synlogics-synb1020-synthetic-biotic-treatment-5853672/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsqs-pharma-receives-ema-approval-for-medicinal-products-manufacturing-5853773/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdhl-opens-new-life-sciences-facility-in-dublin-5854388/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteha-2017-novartis-is-leading-the-car-t-cell-race-5855111/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteha-2017-new-hope-for-multiple-myeloma-patients-5855115/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteha-2017-targeting-the-metabolic-control-of-the-epigenetic-machinery-in-rr-aml-5855132/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteha-2017-bcl-2-as-an-emerging-target-for-aml-5855136/ 2017-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteular-2017-considerations-after-first-tnf-failure-in-ra-5853885/ 2017-06-27T10:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportaml-therapeutics-market-expected-to-diversify-by-2026-5853869/ 2017-06-27T09:52:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-and-premier-collaborate-to-enhance-patient-care-at-reduced-cost-5853031/ 2017-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-and-biological-e-collaborate-to-develop-affordable-combination-vaccines-5853121/ 2017-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalma-and-delphi-genetics-expand-alliance-to-development-plasmid-dna-drugs-5853159/ 2017-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportwhich-class-of-drugs-is-set-to-have-the-biggest-impact-on-the-cancer-market-5853875/ 2017-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbronchitol-gears-up-for-new-drug-application-after-meeting-primary-endpoint-in-phase-iii-trial-5853877/ 2017-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-anti-vaccination-movement-and-public-health-5852820/ 2017-06-26T05:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcould-it-be-third-time-lucky-for-advair-copycats-5852793/ 2017-06-26T04:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresealed-with-a-kisspeptin-the-clinical-potential-of-the-love-hormone-5813120/ 2018-03-15T15:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscardiome-pharmas-xydalba-treatment-for-absssi-available-in-uk-5851643/ 2017-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmhra-grants-positive-eams-scientific-opinion-for-santheras-dmd-treatment-5852388/ 2017-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbrexit-new-alliance-hopes-to-ensure-healthcare-stability-in-an-uncertain-future-5852841/ 2017-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentniche-is-the-new-normal-the-growth-of-the-orphan-drugs-market-5852851/ 2017-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportmonoclonal-antibodies-make-up-seven-out-of-the-top-ten-investigated-drugs-in-2016-5851829/ 2017-06-23T03:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-singapores-pharmaceutical-market-to-reach-12bn-by-2020-5849517/ 2017-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsseqirus-develops-cell-based-influenza-vaccine-at-holly-springs-facility-in-us-5850813/ 2017-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-kuros-biosciences-ag-suda-ltd-prolynx-llc-5850892/ 2017-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-pamplona-capital-management-llp-spherix-inc-quantum-hi-tech-china-biological-co-ltd-5850895/ 2017-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-completes-expansion-of-san-diego-biotechnology-centre-in-us-5850978/ 2017-06-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcopd-severity-differs-by-severity-system-used-5852521/ 2023-01-04T10:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportglioblastoma-could-zika-virus-offer-new-treatment-options-5851054/ 2017-06-22T07:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstherachons-ta-46-receives-fda-and-ema-orphan-drug-designation-for-achondroplasia-5849547/ 2017-06-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-receives-fda-approval-for-mydayis-to-treat-attention-deficit-hyperactivity-disorder-5849578/ 2017-06-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglenmark-signs-license-agreement-for-apc-therapeutics-small-molecule-oncology-compound-5850066/ 2017-06-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdiagnosed-incident-cases-of-cystic-fibrosis-are-set-to-decrease-5851191/ 2017-06-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-60-5849706/ 2023-04-12T06:15:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-finds-way-to-guide-immunotherapy-for-lung-cancer-patients-5848147/ 2017-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswissmedic-accepts-review-on-takedas-filing-submission-of-tigenix-treatment-cx601-5848285/ 2017-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaxis-biotec-to-begin-construction-on-biopharmaceutical-lab-and-manufacturing-facility-in-brazil-5848996/ 2017-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentneupsig-2017-cell-therapies-may-hold-the-key-to-opioid-use-in-neuropathic-pain-5849213/ 2017-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentneupsig-2017-personalized-treatments-may-hold-the-key-to-treatment-progress-in-neuropathic-pain-5849284/ 2017-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteular-2017-big-pharma-dives-back-into-the-lupus-pipeline-5847905/ 2017-06-20T04:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteular-2017-osteoarthritis-pipeline-product-shows-promise-5847902/ 2017-06-20T04:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecounting-the-cost-of-failure-in-drug-development-5813046/ 2021-09-30T14:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-to-sell-medicine-manufacturing-facility-to-sk-biotek-5846957/ 2017-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-sandozs-blood-cancer-and-immunological-disease-treatment-5847027/ 2017-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscompetition-commission-of-south-africa-initiates-investigations-against-pharmaceutical-companies-5847707/ 2017-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgsks-tafenoquine-could-spell-the-end-for-relapsing-p-vivax-malaria-5847855/ 2017-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdevote-trial-confirms-cardiovascular-safety-of-ultra-long-acting-insulin-tresiba-5847992/ 2023-05-08T05:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteular-2017-mixed-expectations-on-use-of-biosimilars-in-rheumatoid-arthritis-5846671/ 2017-06-19T04:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportchina-and-infectious-disease-the-one-to-watch-5846635/ 2018-11-19T14:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnhs-england-approves-kadcyla-for-routine-use-on-nhs-5846086/ 2017-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjj-completes-actelion-acquisition-for-30bn-5846602/ 2021-11-25T10:36:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-janssens-ustekinumab-treatment-for-crohns-disease-5846606/ 2017-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentu-turn-life-prolonging-breast-cancer-drug-now-available-on-the-nhs-5847208/ 2017-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pricing-analytics-next-frontier-for-linking-pricing-and-hta-data-html/ 2021-11-02T03:26:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-chronic-obstructive-pulmonary-disease-market-to-reach-141bn-by-2025-5844159/ 2017-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseco-petroleum-completes-acquisition-of-immunotech-laboratories-5844580/ 2017-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-carma-therapeutics-inc-vectorite-biomedica-inc-loxo-oncology-inc-5845072/ 2017-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentunderstanding-the-risk-of-over-treatment-in-type-2-diabetes-5845275/ 2023-05-08T05:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsintegral-molecular-begins-immuno-oncology-therapeutic-targets-discovery-5845371/ 2017-06-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabcellera-to-discover-antibodies-against-teva-elected-membrane-protein-targets-using-mab-platform-5842982/ 2017-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnih-and-unr-med-researchers-use-unsuccessful-cancer-therapy-to-treat-muscular-dystrophy-5843035/ 2017-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbasilea-pfizer-sign-agreement-to-commercialise-ifd-treatment-cresemba-in-europe-5843957/ 2017-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteular-2017-progress-made-as-scientist-seek-to-unify-lupus-field-5844298/ 2017-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscsl-to-purchase-80-equity-of-chinese-firm-ruide-for-352m-5842402/ 2017-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnumerate-to-develop-ai-driven-clinical-candidates-for-takeda-5841889/ 2023-05-30T04:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-amgens-carfilzomib-with-dexamethasone-for-rmm-treatment-5842009/ 2017-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecould-a-temperature-resistant-vaccine-spell-the-end-for-rabies-and-yellow-fever-5839134/ 2023-04-12T07:14:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentloss-of-exclusivity-to-limit-jj-gain-after-zytiga-label-extension-5841424/ 2017-06-13T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-shows-genetic-faults-can-help-predict-success-of-immunotherapy-in-treating-cancer-5840080/ 2017-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-pharmaceutical-launches-generic-allergic-eye-treatment-pataday-in-us-5840208/ 2017-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-johnson-johnsons-proposed-acquisition-of-actelion-5841230/ 2017-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-and-keybioscience-collaborate-to-develop-potential-type-2-diabetes-treatment-5838359/ 2017-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-drug-designation-to-mithras-e4-treatment-for-neonatal-encephalopathy-5838944/ 2017-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-pharmaceuticals-to-sell-its-inova-business-for-930m-5840561/ 2017-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-venous-thromboembolism-market-to-grow-at-a-cagr-of-387-5837092/ 2022-08-02T10:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-sell-global-rights-for-migraine-treatment-zomig-to-grnenthal-5837289/ 2017-06-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-discovers-innovative-immunotherapy-treatment-to-cure-brca1-breast-cancer-5837389/ 2017-06-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-exact-sciences-corporation-egalet-corporation-tisbury-pharmaceuticals-ltd-5838232/ 2017-06-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/outcry-over-patient-death-puts-hong-kongs-drug-reimbursement-system-into-spotlight-html/ 2021-11-02T03:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroivant-forms-new-subsidiary-to-develop-urology-therapies-5836970/ 2022-11-14T13:44:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssynlogic-completes-first-phase-in-ongoing-rd-collaboration-with-abbvie-5836979/ 2017-06-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-breakthrough-therapy-designation-to-msks-burtomab-neuroblastoma-therapy-5837119/ 2023-01-11T18:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentchemo-free-triplet-regimens-on-the-horizon-for-cll-5835839/ 2017-06-07T03:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentopportunities-for-abemaciclib-in-the-future-5835080/ 2017-06-07T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslundbeck-secures-rights-to-ibcs-research-for-alzheimers-treatment-5835831/ 2017-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspurdue-pharma-to-distribute-helsinns-cinv-injection-aloxi-in-canada-5835847/ 2017-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-status-to-pfizers-tafamidis-to-treat-ttr-cm-5835861/ 2017-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-gene-silencing-approach-to-cutting-cholesterol-5836319/ 2023-02-10T12:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpractice-changing-results-at-the-asco-conference-lynparza-is-poised-to-modify-the-treatment-paradigm-of-metastatic-breast-cancer-5835083/ 2017-06-06T10:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-and-f-star-to-develop-five-bispecific-immuno-oncology-antibodies-5834081/ 2017-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremays-top-stories-thermo-fisher-scientific-agrees-to-buy-patheon-for-72bn-astrazeneca-signs-deal-to-sell-commercial-rights-for-seloken-in-europe-5834239/ 2017-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-and-ibm-watson-to-optimise-cancer-care-and-patient-outcomes-5834592/ 2017-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsveloxis-pharma-signs-agreements-to-commercialise-envarsus-xr-in-china-taiwan-and-canada-5834604/ 2017-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpoor-tolerability-of-opdivo-yervoy-in-frontline-nsclc-could-be-achilles-heel-5833148/ 2017-06-05T04:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepooling-resources-for-clinical-trials-5819198/ 2022-07-11T08:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssurface-oncology-enters-into-licence-agreement-to-use-ligands-omniab-platform-5832392/ 2017-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-nih-study-reveal-mutations-in-the-gene-cables1-may-lead-to-cushing-syndrome-5832491/ 2017-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinnate-pharma-acquires-anti-c5ar-antibody-from-novo-nordisk-5833353/ 2017-06-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstd2-and-deep-6-ai-collaborate-to-find-cancer-patients-for-appropriate-clinical-trials-in-minutes-5831307/ 2022-07-11T08:56:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-marketing-authorisation-for-biogens-5q-sma-treatment-5831380/ 2017-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-inthera-bioscience-ag-i2-pharmaceuticals-inc-inventisbio-inc-5831822/ 2017-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-inspyr-therapeutics-inc-nissui-pharmaceutical-co-ltd-5831828/ 2017-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaequus-and-cdrd-to-jointly-improve-cannabinoid-based-therapeutics-5832036/ 2017-06-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnovartis-pfizer-amgen-and-merck-key-players-in-the-autoimmune-biosimilars-space-5831497/ 2017-06-01T08:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportema-set-to-approve-plethora-of-oncology-drugs-5830918/ 2017-06-01T04:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportoncology-remains-top-orphan-drug-designation-choice-for-companies-after-5-years-5830895/ 2017-06-01T04:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-gets-ec-approval-for-trumenba-to-prevent-menb-disease-in-adolescents-and-young-adults-5829438/ 2017-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsreport-shows-medical-research-collaboration-between-uk-and-uk-benefits-patients-across-europe-5829543/ 2017-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschiltern-buys-ida-to-integrate-japan-and-asia-into-global-drug-development-5830333/ 2017-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-indications-and-therapy-areas-for-2012-2016-clinical-trials-in-israel-5831045/ 2017-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentaeries-ophthalmic-candidate-succeeds-in-registration-trial-5828408/ 2023-04-14T09:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentincreased-risk-of-amputation-if-taking-type-2-diabetes-drug-invokana-5829395/ 2017-05-31T03:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-politics-of-oil-wreak-havoc-on-access-to-medicines-html/ 2021-11-02T03:26:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmithra-receives-ma-for-tibelia-in-france-to-address-menopausal-symptoms-5828792/ 2021-11-22T13:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-fast-track-designation-for-amo-pharmas-congenital-myotonic-dystrophy-treatment-5828824/ 2017-05-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjanssen-and-protagonist-collaborate-to-develop-treatment-for-inflammatory-bowel-disease-5829125/ 2017-05-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttransferring-technology-from-concept-to-commercialisation-5828434/ 2017-05-30T05:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureare-cheap-canadian-drugs-a-solution-to-us-pricing-issues-5819405/ 2018-04-17T15:52:57+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/newsteijin-pharma-merck-collaborate-to-develop-anti-tau-antibody-5826748/ 2017-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-priority-review-for-kite-pharmas-refractory-aggressive-nhl-treatment-5826837/ 2017-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrc-approves-new-vaccine-to-counter-ebola-virus-in-country-5828027/ 2017-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnew-treatments-will-soon-be-available-for-long-neglected-nash-sufferers-5828129/ 2017-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentroundup-of-key-oncology-strategic-alliances-in-q1-2017-5828207/ 2017-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-global-burden-of-rheumatoid-arthritis-will-increase-5825875/ 2017-05-26T05:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportorphan-cancer-drugs-take-up-37-of-market-share-5825834/ 2017-05-26T05:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentis-teva-doomed-after-copaxones-increased-competition-and-laquinimods-failed-phase-iii-trial-5825817/ 2017-05-26T05:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-scivision-biotech-inc-symic-biomedical-inc-palladio-biosciences-inc-5823966/ 2017-05-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-growth-hormone-deficiency-market-to-surpass-2bn-by-2026-5824329/ 2017-05-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspierre-fabre-to-buy-igenica-biotherapeutics-assets-for-treating-cancer-patients-5824653/ 2022-07-11T08:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-university-of-sheffield-study-into-drug-candidate-for-mnd-delivers-positive-results-5824776/ 2017-05-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnew-drug-class-set-to-reduce-migraine-misery-5826339/ 2017-05-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportus-and-uk-stand-out-with-higher-disease-prevalence-of-two-autoimmune-diseases-5825044/ 2017-05-25T09:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbioverativ-to-purchase-true-north-therapeutics-for-400m-5822711/ 2017-05-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsunisys-unveils-pharmatrack-software-to-manage-global-pharmaceutical-supply-chain-5823338/ 2022-07-11T08:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-sun-pharmas-tildrakizumab-for-moderate-to-severe-plaque-psoriasis-5824152/ 2017-05-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthighlights-from-the-2017-ats-conference-5823717/ 2017-05-24T10:41:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentartificial-intelligence-the-beginning-of-a-new-era-in-healthcare-5823549/ 2022-11-23T12:17:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-launch-of-long-acting-therapies-will-drive-the-growth-of-the-growth-hormone-meficiency-market-5823534/ 2017-05-24T07:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/us-healthcare-reform-caught-between-a-rock-and-a-hard-place-html/ 2021-11-02T03:26:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsselexis-and-ose-immunotherapeutics-to-support-ose-127-effi-7-development-5822785/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-cma-accuses-merck-of-breaking-competition-law-with-discount-scheme-5822959/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-sanofi-regenerons-kevzara-for-adult-rheumatoid-arthritis-5822982/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpipeline-biosimilar-surge-in-emerging-markets-5823319/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsardelyxs-first-in-class-nhe3-blocker-tenapanor-boasts-positive-phase-iii-data-5823329/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthiv-and-malaria-case-studies-in-combatting-drug-resistance-through-improved-adherence-5841505/ 2017-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/us-healthcare-reform-the-ispor-debate-html/ 2021-11-02T03:26:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthow-your-gut-microbiome-can-interfere-with-cancer-treatment-and-how-to-avoid-it-5821558/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcan-daa-treatment-increase-the-risk-of-hcc-emerging-data-points-towards-no-5821565/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportis-diagnosed-non-invasive-ductal-carcinoma-in-situ-breast-cancer-rarer-in-china-5821573/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsac-immune-essex-to-co-develop-biological-therapeutic-for-neurodegenerative-diseases-and-neuroinflammation-5821748/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-signs-deal-to-sell-commercial-rights-for-seloken-in-europe-5821761/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssingapore-edevelopment-subsidiary-initiates-advanced-research-on-linebacker-5821773/ 2017-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthighlights-from-the-2017-ats-conference-positive-results-for-astrazenecas-daliresp-beyond-reducing-the-risk-of-exacerbations-5821041/ 2017-05-22T09:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenteiger-bios-pah-drug-ubenimex-moves-one-step-closer-to-fulfilling-an-unmet-need-5820368/ 2017-05-22T03:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentseikagaku-inks-deal-with-ono-pharmaceutical-strengthening-its-position-in-the-osteoarthritis-market-5820331/ 2017-05-22T03:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbaxaltas-patent-war-on-hemophilia-a-candidate-emicizumab-could-make-roche-bleed-5820346/ 2017-05-22T03:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/meet-us-at-ispor-boston-booth-204-html/ 2021-11-02T03:26:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofis-insulin-lispro-receives-chmp-positive-opinion-to-treat-diabetes-5819420/ 2017-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecanadas-stem-cell-contender-5819576/ 2021-02-25T15:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportanticipated-approval-timeline-of-parp-inhibitors-in-her2-negative-breast-cancer-5820468/ 2022-01-20T20:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-isentress-receives-chmp-positive-opinion-to-treat-hiv-1-infection-5820551/ 2017-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-funded-scientists-to-test-zika-virus-on-brain-tumours-5820568/ 2017-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpacific-biosciences-dont-count-them-out-yet-5821052/ 2017-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-german-pharmaceuticals-market-set-to-grow-at-a-cagr-of-49-by-2021-5816467/ 2017-05-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-lonza-group-ltd-shandong-buchang-pharmaceutical-co-ltd-5817279/ 2021-11-14T13:18:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-shanghai-fosun-pharmaceutical-group-co-ltd-shandong-buchang-pharmaceutical-co-ltd-4sc-ag-5817314/ 2021-11-22T08:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssobi-receives-sfda-approval-for-orfadin-capsules-5818417/ 2017-05-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnppa-issues-notice-to-pharmaceutical-firms-for-non-compliance-of-pricing-provisions-5818457/ 2017-05-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportcost-containment-remains-strategic-driver-in-outsourcing-sector-5817704/ 2017-05-18T04:06:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremicro-machines-nanotech-offers-new-possibilities-for-disease-detection-and-drug-delivery-5810319/ 2017-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsx-chem-and-vertex-form-multi-target-genetic-disease-collaboration-5817148/ 2017-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-receives-fda-priority-review-for-copanlisib-to-treat-follicular-lymphoma-5817162/ 2017-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsst-asia-signs-licensing-agreement-with-pharmamar-for-anti-cancer-compound-lurbinectedin-5817575/ 2017-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-59-5816891/ 2023-04-12T06:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscytokinetics-receives-fda-orphan-drug-status-for-ck-2127107-to-treat-sma-5816411/ 2021-11-25T09:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvifor-pharma-and-akebia-to-sell-vadadustat-to-fresenius-medical-care-5816422/ 2017-05-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsboehringer-opens-biopharmaceutical-manufacturing-facility-in-china-5816455/ 2017-05-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmanufacturers-and-contract-packagers-may-miss-serialisation-deadlines-claims-research-5814501/ 2017-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseu-nations-urge-funding-to-research-new-drugs-and-vaccines-for-tuberculosis-5814821/ 2017-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthermo-fisher-scientific-agrees-to-buy-patheon-for-72bn-5814842/ 2017-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseli-lilly-scores-phase-iii-migraine-success-with-galcanezumab-5815661/ 2017-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssynthetic-biologics-syn-004-awarded-breakthrough-therapy-designation-by-fda-5813355/ 2017-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-and-pakistan-sign-deal-to-provide-free-medicine-for-chronic-diseases-5813832/ 2017-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizers-13-valent-pcv-selected-in-indias-immunisation-programme-5813842/ 2017-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurechallenging-the-link-between-pharma-innovation-and-us-drug-pricing-5813154/ 2017-05-12T10:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebrain-boosters-exploring-the-grey-area-of-off-label-smart-drugs-5813135/ 2017-05-12T09:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-allergan-plc-biocryst-pharmaceuticals-inc-oncodesign-sa-5812211/ 2017-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-wirb-copernicus-group-otsuka-pharmaceutical-factory-inc-5812215/ 2017-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelyad-receives-fda-fast-track-designation-for-c-cure-to-treat-ischemic-heart-failure-5812594/ 2017-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnorgine-agrees-to-buy-merus-labs-for-342m-5812602/ 2017-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-issues-crl-to-hikmas-generic-version-of-gsks-advair-diskus-5812900/ 2017-05-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-signs-collaboration-deal-with-gammadelta-therapeutics-for-t-cell-therapy-5811308/ 2017-05-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-bavencio-for-advanced-bladder-cancer-treatment-5811331/ 2017-05-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstudy-finds-painkillers-to-increase-heart-attack-risk-within-first-week-of-usage-5811375/ 2017-05-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/can-affordable-medicines-become-a-reality-for-ukraine-html/ 2021-11-02T03:26:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsexscientia-signs-collaboration-deal-with-sanofi-for-multiple-product-development-5809801/ 2017-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-receives-fda-approval-for-kisqali-femara-co-pack-to-treat-metastatic-breast-cancer-5809826/ 2017-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseusa-pharma-receives-ec-approval-for-dinutuximab-beta-antibody-to-treat-neuroblastoma-5810059/ 2017-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentradicava-first-new-treatment-for-als-approved-by-fda-after-two-decades-5808969/ 2017-05-09T08:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgilead-and-abbvie-look-to-fill-remaining-gaps-in-hepatitis-c-treatment-5808354/ 2017-05-09T03:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrown-bioscience-collaborates-with-jiangsu-qyun-to-develop-ctla-4-antibody-5808500/ 2017-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentlundbeck-and-otsukas-brexipiprazole-shows-positive-but-confusing-results-5808520/ 2017-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmt-pharma-americas-radicava-gets-fda-approval-to-treat-als-5808591/ 2017-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdurect-and-sandoz-sign-293m-deal-to-commercialise-posimir-in-us-5808618/ 2017-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-receives-european-commission-approval-for-keytruda-to-treat-relapsed-hodgkin-lymphoma-5806667/ 2023-01-19T06:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfmt-national-registry-will-help-elucidate-best-practices-for-recurrent-c-difficile-infections-5807053/ 2017-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenthepatitis-c-therapy-a-light-at-the-end-of-the-tunnel-5807061/ 2017-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimmunocore-and-gsk-identify-second-new-immtac-for-cancer-treatment-5807067/ 2017-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecrowdfunding-for-cancer-therapy-5806072/ 2017-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsproterris-and-alfama-completes-merger-to-create-carbon-monoxide-therapy-leader-5806646/ 2017-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-collaborative-project-launched-to-engage-universities-in-drug-discovery-for-neglected-diseases-5805428/ 2017-05-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-spanish-pharmaceutical-market-to-witness-a-modest-growth-rate-of-1-by-2021-5805668/ 2017-05-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-amag-pharmaceuticals-inc-noxxon-pharma-nv-teewinot-life-sciences-corp-5805717/ 2017-05-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-huapont-life-sciences-sosei-group-corp-5805748/ 2017-05-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdementia-discovery-fund-to-invest-5m-in-cerevance-to-advance-alzheimers-treatment-5804013/ 2017-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsservier-and-miragen-extend-collaboration-to-commericalise-microrna-targeting-therapeutics-5804023/ 2017-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsperrigo-offices-searched-by-us-justice-department-over-drug-pricing-probe-5804851/ 2017-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-invests-139m-to-increase-benlysta-belimumab-production-capacity-5804873/ 2017-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentchina-us-and-brazil-face-rise-in-hiv-hcv-co-infection-5805327/ 2017-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/austria-hastily-implemented-legal-changes-hit-pharma-industry-html/ 2021-11-02T03:26:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-court-of-appeals-reverses-district-court-judgment-for-antiemetic-agent-aloxi-5802338/ 2017-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-receives-fda-accelerated-approval-for-imfinzi-5802649/ 2022-01-20T20:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaxim-biotech-receives-permission-to-advance-medchew-chewing-gum-development-5802906/ 2017-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporta-look-at-atrial-fibrillations-market-size-forecast-5802059/ 2017-05-02T04:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureaprils-top-stories-cn-bio-licences-hepatitis-b-drug-astellas-to-acquire-ogeda-for-800m-5800044/ 2017-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-receives-fda-approval-for-rydapt-to-treat-acute-myeloid-leukemia-and-mastocytosis-5800894/ 2023-05-10T04:43:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsatlantic-healthcare-to-submit-nda-for-alicaforsen-in-the-treatment-of-pouchitis-5800924/ 2017-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsshire-gains-rights-to-develop-commercialise-p-321-for-ophthalmic-indications-5801925/ 2017-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportindustry-sponsored-clinical-trials-initiated-in-q1-2017-5802424/ 2017-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovartis-boosts-ophthalmology-pipeline-by-in-licensing-clinical-stage-dry-eye-therapy-5802448/ 2021-12-01T12:38:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfdas-acceptance-of-santens-opsiria-marks-a-milestone-for-the-company-5802460/ 2017-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportwill-competitive-us-pricing-be-enough-to-give-valeants-siliq-an-edge-5800263/ 2017-04-28T09:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportlicensing-deals-in-duchenne-muscular-dystrophy-dmd-5799806/ 2017-04-28T04:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-likely-relocation-of-the-ema-is-bad-news-for-the-pharmaceutical-industry-and-the-health-of-500-million-europeans-5799787/ 2017-04-28T04:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportchina-shows-leading-emerging-market-growth-in-rd-spend-5799777/ 2017-04-28T04:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-sponsors-and-cros-for-2012-2016-clinical-trials-in-israel-5799709/ 2017-04-28T04:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-contravir-pharmaceuticals-inc-urogen-pharmaceuticals-ltd-fresenius-se-co-kgaa-5797810/ 2017-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-serum-institute-of-india-ltd-fresenius-se-co-kgaa-nanocarrier-co-ltd-5797818/ 2017-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseu-awards-conditional-marketing-authorisation-for-shires-natpar-5799098/ 2017-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspiqur-therapeutics-pqr309-granted-ema-orphan-drug-designation-5799122/ 2017-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-and-harrington-discovery-institute-to-advance-rare-disease-therapeutics-development-5799901/ 2017-04-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportinnovate-new-drugs-could-produce-a-watershed-moment-for-dermatology-sufferers-5798990/ 2017-04-27T09:37:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportrapid-expansion-of-biosimilar-trials-between-2007-and-2016-5798989/ 2017-04-27T09:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-ixekizumab-taltz-to-treat-severe-plaque-psoriasis-5798446/ 2017-04-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsservier-and-cti-biopharma-to-expand-collaboration-to-commericalise-pixuvri-5798480/ 2017-04-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstudying-unstable-chromosomes-can-help-to-predict-cancer-relapse-says-cancer-research-uk-5798590/ 2017-04-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-and-amgen-expand-global-collaboration-to-commercialise-amg-334-5796348/ 2017-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-study-confirms-effectiveness-of-bcm-95-to-treat-colitis-5796357/ 2017-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-ncri-introduces-five-year-strategy-to-advance-cancer-research-5797127/ 2017-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentresearchers-raise-hope-for-affordable-malaria-diagnostics-5796042/ 2023-03-31T10:40:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregeneron-and-sanofi-gets-chmp-endorsement-for-kevzara-to-treat-rheumatoid-arthritis-5795009/ 2017-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssamsung-bioepis-receives-fda-approval-for-renflexis-across-all-eligible-indications-5795018/ 2017-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsparatek-pharmaceuticals-and-zai-lab-sign-deal-to-commercialise-omadacycline-in-china-5795174/ 2017-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentagioss-enasidenib-is-on-track-to-become-the-first-idh2-inhibitor-approved-in-aml-5796150/ 2017-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentworld-malaria-day-2017-focus-on-prevention-5796223/ 2017-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportpharma-licensing-deals-20162017-comparison-5794903/ 2017-04-24T10:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/comment23andme-bringing-early-diagnosis-of-type-1-gaucher-disease-one-step-closer-5794898/ 2022-09-01T13:23:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpcr-based-c-difficile-cytotoxin-assays-alone-not-appropriate-for-pivotal-endpoint-measures-5794494/ 2017-04-24T05:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmpp-sign-licence-and-technology-transfer-agreement-with-pharco-pharmaceuticals-for-rav-5794053/ 2017-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleants-plaque-psoriasis-drug-to-cost-3500-a-month-5794062/ 2017-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiomarins-brineura-receives-positive-opinion-from-chmp-to-treat-cln2-disease-5794238/ 2023-03-23T11:07:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwhos-first-global-hepatitis-report-aims-high-elimination-of-hepatitis-b-and-c-by-2030-5794781/ 2017-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnewest-class-of-type-2-diabetes-drugs-continues-its-push-into-the-us-market-5794812/ 2017-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentchinas-pharma-market-transformation-to-fuel-global-industry-growth-5794875/ 2017-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmore-than-just-a-pretty-face-botox-set-to-combat-depression-5793543/ 2017-04-21T07:54:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-bladder-cancer-market-to-grow-at-a-cagr-of-125-up-to-2025-5792246/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsparvus-therapeutics-signs-collaboration-agreement-with-novartis-to-commercialise-navacim-5792659/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-livzon-pharmaceutical-group-plx-pharma-medis-laboratories-5792789/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-grifols-cellesce-arena-pharmaceuticals-5793038/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsionis-ribo-partner-to-commercialise-rna-targeted-therapeutics-in-china-5793059/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentrecurring-c-difficile-infections-cause-havoc-in-hospitals-in-scotland-and-england-5793201/ 2017-04-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportinorganic-growth-continues-to-fuel-outsourcing-sector-5792488/ 2017-04-20T10:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcuring-hepatitis-c-a-double-edged-sword-for-liver-transplant-candidates-5792486/ 2017-04-20T09:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenarrowing-the-hunt-for-nanoparticles-5776258/ 2017-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsplx-pharma-merges-with-dipexium-pharmaceuticals-5791800/ 2017-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-daiichi-sankyo-jv-submits-nda-for-candidate-shingles-vaccine-in-japan-5791833/ 2017-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshitgen-pfizer-partnerto-buildand-screen-new-dna-encoded-libraries-5791852/ 2017-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentsmall-but-mighty-nanotechnology-in-cancer-therapy-5791194/ 2017-04-19T09:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-58-5791122/ 2023-04-12T06:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrigel-pharmaceuticals-files-new-drug-application-to-fda-for-chronic-itp-treatment-5789958/ 2017-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-car-t-cell-therapy-awarded-fda-breakthrough-therapy-designation-for-dlbcl-treatment-5789968/ 2017-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-cpf-and-nci-to-develop-tests-to-analyse-ras-inhibitors-5790448/ 2017-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportbrazil-2016-clinical-trials-activity-at-lowest-point-in-five-years-5791108/ 2017-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalks-hdm-tablet-acarizax-gets-approval-for-expansion-in-12-european-countries-5788404/ 2017-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-declines-approval-of-eli-lilly-and-incytes-baricitinib-drug-to-treat-ra-5788459/ 2017-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpharma-price-hiking-why-does-it-happen-5789214/ 2017-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgenentechs-tecentriq-gets-fda-accelerated-approval-for-advanced-bladder-cancer-treatment-5789304/ 2017-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmundipharma-to-market-invossa-in-korea-marking-another-strategic-partnership-for-kolon-life-science-5789319/ 2017-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/nordics-inch-toward-cooperation-on-drug-purchasing-but-dont-expect-early-developments-html/ 2022-10-21T16:59:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-frequency-therapeutics-emerald-health-therapeutics-immune-system-regulation-holding-5785946/ 2017-04-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-unitedhealth-stada-arzneimittel-fresenius-5785978/ 2021-11-22T07:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporteylea-enables-regeneron-to-dominate-the-ocular-market-5786811/ 2017-04-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-nubiyota-to-develop-microbial-ecosystem-therapeutic-products-for-gi-indications-5786894/ 2017-04-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsappili-to-develop-new-antibiotic-to-treat-gram-negative-infections-5786904/ 2023-06-12T04:10:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-neurocrines-ingrezza-capsules-to-treat-tardive-dyskinesia-5786933/ 2021-12-02T07:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttargeting-of-specific-patient-groups-to-break-into-the-epilepsy-market-5785679/ 2017-04-12T04:43:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnices-draft-guidance-ignores-recommendation-of-opdivo-to-treat-cancer-bristol-myers-squibb-says-5785731/ 2017-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssmc-approves-anti-hiv-drug-prep-5785742/ 2017-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-scientists-identify-weak-spot-in-zika-virus-proteins-5785815/ 2017-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentuncertainty-grows-for-immuno-oncology-therapies-in-glioblastoma-multiform-5786007/ 2023-01-19T06:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscbmg-ge-partner-to-co-develop-control-processes-in-car-t-and-stem-cell-manufacturing-5784306/ 2017-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaustrian-scientists-modify-and-reinforce-host-defence-peptide-from-breast-milk-to-detect-cancer-cells-5784325/ 2017-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszambon-launches-xadago-in-portugal-to-treat-parkinsons-disease-5784332/ 2017-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentheading-for-the-future-transplants-and-the-pharma-market-5784337/ 2017-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdark-clouds-the-growing-burden-of-major-depressive-disorder-5783477/ 2017-04-10T06:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentsupernus-pharmaceuticals-expands-neurology-portfolio-with-label-extension-of-trokendi-xr-5783394/ 2017-04-10T05:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharmaceutical-packaging-where-should-drug-companies-focus-their-efforts-5775849/ 2017-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssynergy-pharmaceuticals-launches-new-poop-troop-emoji-keyboard-app-for-cic-5783234/ 2017-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshikma-signs-settlement-agreement-over-jazzs-xyrem-patent-litigation-5783243/ 2017-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimmune-onc-ut-system-to-develop-new-biotherapeutics-for-cancer-immunotherapy-5783258/ 2017-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-capital-international-apollo-capital-5780773/ 2021-10-29T05:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-hutchison-china-meditech-ltd-eastgate-biotech-corp-tocagen-inc-5780902/ 2017-04-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshyundai-pharm-files-for-marketing-approval-of-natesto-in-south-korea-5781950/ 2017-04-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-to-in-licence-ecf843-for-ophthalmic-indications-globally-5781958/ 2021-12-01T12:38:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssupernuss-sndas-receive-final-fda-approval-for-trokendi-xr-for-migraine-prophylaxis-5781971/ 2017-04-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurealzheimers-drugs-will-2017-bring-better-news-5775766/ 2017-04-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsredhill-biopharmas-yeliva-obtains-orphan-drug-designation-from-us-fda-5780766/ 2022-12-29T07:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallied-minds-cuts-funding-to-seven-subsidiaries-5780779/ 2017-04-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscn-bio-licences-hepatitis-b-drug-discovery-programme-from-bristol-myers-squibb-5780798/ 2017-04-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentphrma-puts-blame-squarely-on-insurers-in-new-drug-spending-report-5780941/ 2017-04-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-tevas-austedo-tablets-to-treat-chorea-associated-with-hd-5779386/ 2017-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsku-leuven-led-consortium-to-develop-new-vaccine-against-rabies-and-yellow-fever-5779406/ 2017-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-meiji-to-commercialise-safinamide-for-parkinsons-disease-in-japan-and-asia-5779643/ 2017-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportuks-young-adults-using-the-web-for-medical-advice-5778201/ 2017-04-04T04:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovo-nordisks-refixia-what-are-its-prospects-in-the-hemophilia-b-space-5778243/ 2017-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmundipharmas-mundesine-receives-approval-from-japans-mhlw-to-treat-ptcl-5778379/ 2017-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-pharma-to-acquire-belgiums-ogeda-for-800m-5778396/ 2017-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssucampo-pharmaceuticals-acquires-rare-disease-company-vtesse-for-200m-5778412/ 2017-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-pharma-forecasted-sales-underestimated-by-analysts-5776867/ 2017-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremarchs-top-stories-2017-5776891/ 2017-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnhs-england-updates-new-five-year-forward-view-5777076/ 2017-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-mmv-launch-new-programme-to-find-lead-compounds-for-malaria-treatment-5777088/ 2017-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-develop-new-approach-to-improve-hiv-vaccine-effectiveness-5777094/ 2017-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecancergraph-a-desperately-needed-link-between-patient-and-clinical-trial-5776267/ 2017-03-31T09:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-oncology-revenue-generators-what-will-the-next-five-years-bring-5775687/ 2017-03-31T03:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-mesoblast-limited-orexigen-therapeutics-ireland-ltd-savior-lifetec-corporation-5774391/ 2021-11-22T09:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-protext-mobility-yichang-hec-changjiang-pharma-5774419/ 2017-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-companies-adopting-innovative-strategies-to-compete-in-the-tauopathies-space-5774501/ 2017-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprometic-sram-jv-to-develop-commercialise-three-drug-candidates-in-china-5775719/ 2017-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsg-ba-confirms-additional-benefit-of-eisais-kisplyx-to-treat-advanced-rcc-5775751/ 2017-03-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporta-serious-threat-on-the-horizon-for-imbruvica-5774954/ 2017-03-30T08:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentroche-expected-to-remain-an-ovarian-cancer-drug-market-leader-5774925/ 2017-03-30T07:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureilluminating-drug-discovery-by-mapping-all-known-drugs-5760860/ 2017-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-dupixent-to-treat-atopic-dermatitis-in-adults-5774609/ 2017-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-drug-designation-to-gw-pharmaceuticals-epidiolex-5774629/ 2017-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnosopharm-raises-funds-to-accelerate-development-of-noso-95179-molecule-5774635/ 2017-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentfda-raises-warning-flag-over-viberzi-safety-in-ibs-d-5773857/ 2023-01-04T11:15:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbial-and-eisai-receive-positive-opinion-for-zebinix-to-treat-adults-with-focal-onset-epilepsy-5773217/ 2017-03-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentinclisiran-a-novel-approach-to-targeting-cholesterol-and-patient-needs-5773859/ 2022-07-11T08:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportindias-2016-clinical-trials-activity-back-to-2008-levels-5773915/ 2017-03-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentroches-ocrevus-expected-to-be-a-game-changer-for-the-multiple-sclerosis-market-5773916/ 2017-03-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-issues-positive-opinion-for-eusa-pharmas-dinutuximab-beta-to-treat-neuroblastoma-5773028/ 2017-03-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttrumps-new-fda-commissioner-a-reasonable-pick-despite-conflicts-of-interest-5773067/ 2017-03-28T03:48:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-pfizers-xeljanz-to-treat-rheumatoid-arthritis-in-eu-5772967/ 2017-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsicr-scientists-uncover-information-about-genetic-causes-of-brain-cancer-5773001/ 2017-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsperrigo-completes-sale-of-tysabri-drug-royalty-to-rpi-for-285bn-5773018/ 2017-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnovo-nordisks-long-acting-growth-hormone-somapacitan-likely-to-conquer-the-adult-ghd-market-in-japan-5773191/ 2023-03-10T05:38:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportseven-kings-of-diabetes-will-remain-in-power-for-years-to-come-5773644/ 2017-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportbiogen-will-retain-the-lions-share-of-the-neurology-market-5773652/ 2017-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnovartis-most-clinical-trials-initiated-in-a-year-5772047/ 2017-03-27T04:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/international-reference-pricing-love-it-or-hate-it-there-is-a-good-way-and-a-bad-way-to-do-it-html/ 2021-11-02T03:26:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspuretech-health-novartis-to-advance-clinical-stage-programmes-5771917/ 2017-03-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-pfizer-secure-us-fda-approval-for-bavencio-to-treat-skin-cancer-5771929/ 2023-02-03T08:52:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsleukaemia-cares-research-finds-inequalities-in-cancer-care-for-elderly-patients-5771943/ 2017-03-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnewron-pharmaceuticals-finally-gets-fda-approval-for-parkinsons-medication-5772063/ 2017-03-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcrispr-cas-9-genome-editing-heralds-a-revolution-in-healthcare-5771495/ 2017-03-24T10:54:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpersonalised-medicine-a-paradigm-shift-in-treatment-5771494/ 2023-06-19T06:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportuk-and-australian-health-authorities-disagree-over-e-cigarettes-5771356/ 2017-03-24T07:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttrumps-budget-america-first-but-americans-last-5771064/ 2017-03-24T05:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-ascend-therapeutics-us-llc-tyme-technologies-inc-axsome-therapeutics-inc-5770644/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-sun-moral-international-hk-ltd-immuno-holding-sa-de-cv-5770731/ 2021-11-22T12:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalexion-submits-application-to-japans-mhlw-to-extend-soliris-indication-to-treat-gmg-5770960/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrgc-uk-biobank-and-gsk-launch-new-initiative-to-improve-disease-diagnosis-5770968/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-to-support-precision-panc-project-for-pancreatic-cancer-5770984/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentgileads-aggressive-promotion-of-its-taf-based-hiv-portfolio-already-yielding-results-5771127/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdetecting-aml-subtype-the-key-to-better-targeted-drugs-5771315/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttoxicity-pricing-and-combinatory-strategies-will-drive-competition-amongst-cdk46-inhibitors-5771322/ 2017-03-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-growing-burden-of-art-resistant-hiv-5770080/ 2017-03-23T06:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportsurge-in-deals-promises-a-brighter-future-for-fatty-liver-disease-5770006/ 2017-03-23T05:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-fast-track-designation-for-shires-shp655-5769697/ 2017-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsargenx-broteio-pharma-partner-to-develop-antibody-for-autoimmune-diseases-5769709/ 2021-11-22T09:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbc-to-provide-public-access-to-gilead-sciences-epclusa-for-genotype-1-6-hcv-5769723/ 2017-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnon-profit-licensing-deal-values-climb-in-2016-5769269/ 2017-03-22T11:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-57-5769240/ 2023-04-12T06:29:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsferrier-research-institute-and-bcfnz-to-create-new-breast-cancer-vaccine-5768721/ 2017-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspierre-fabre-h-immune-to-develop-new-cancer-immunotherapies-5768739/ 2017-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-approves-xadago-to-treat-patients-with-parkinsons-disease-5768749/ 2017-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpersonalised-medicine-is-the-future-of-cancer-treatment-5768239/ 2017-03-21T10:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmove-over-zika-and-ebola-the-next-global-epidemic-could-be-metabolic-5768232/ 2017-03-21T10:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnon-alcoholic-steatohepatitis-cases-expected-to-nearly-double-over-next-decade-5768230/ 2023-01-30T15:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/cross-country-procurement-will-it-soon-be-the-bane-of-pharmas-existence-html/ 2021-11-02T03:27:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsemergent-signs-100m-barda-contract-to-deliver-biothrax-5767830/ 2017-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspcc-acquires-intrathecal-therapy-business-from-mallinckrodt-for-203m-5767837/ 2017-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscannrx-icanisrael-cannabis-form-jv-to-launch-sleep-cannabis-formulation-5767859/ 2017-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureturning-to-turmeric-exciting-drug-candidate-or-another-dead-end-5743153/ 2017-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscircassia-to-acquire-us-commercial-rights-for-astrazenecas-tudorza-and-duaklir-copd-products-5765655/ 2017-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-rejects-use-of-daratumumab-darzalex-monotherapy-for-treatment-of-myeloma-5765946/ 2017-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbellus-health-agrees-to-sell-thallion-to-us-firm-taro-pharmaceuticals-5766844/ 2017-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpharmacoeconomics-a-crushing-reality-in-todays-industry-5766145/ 2017-03-17T10:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/three-trends-that-will-shape-eu-market-access-in-the-next-decade-html/ 2021-11-02T03:27:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-innopharmax-aurinia-pharmaceuticals-hainan-poly-pharm-5764279/ 2017-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalzheimers-research-uk-expresses-concern-over-nices-new-budget-impact-test-5765107/ 2017-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdiurnal-clinigen-partner-to-introduce-patient-access-programme-for-unlicensed-products-in-europe-5765108/ 2023-04-04T08:47:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoxford-biodynamics-to-conduct-study-to-identify-biological-factors-that-causes-ra-flares-5765604/ 2017-03-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofis-dupilumab-receives-mhra-positive-scientific-opinion-to-treat-atopic-dermatitis-5763055/ 2017-03-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-denies-preliminary-access-to-bristol-myers-squibbs-nivolumab-for-aggressive-blood-cancer-5763086/ 2017-03-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-submits-application-to-fda-for-expanded-indication-of-influenza-vaccine-5764403/ 2017-03-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalzheimers-research-uk-report-reveals-doubling-of-dementia-researchers-over-six-years-5762301/ 2017-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-report-reveals-that-uk-lags-behind-in-patients-access-to-treatment-for-rare-disease-5762365/ 2017-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmhlw-grants-priority-review-for-abbvies-chronic-hcv-treatment-5763016/ 2017-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentantibiotic-stewardship-can-we-learn-from-englands-c-difficile-success-5762637/ 2017-03-14T10:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsswansea-university-scientists-assess-genetics-of-common-epilepsy-5761550/ 2017-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsicr-study-reveals-hodgkin-lymphoma-survivors-to-be-at-increased-risk-of-second-cancers-5761952/ 2017-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-novartiss-kisqali-for-patients-with-hrher2-advanced-or-metastatic-breast-cancer-5762017/ 2017-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebluerock-therapeutics-ontarios-home-grown-stem-cell-contender-5762232/ 2017-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretakeda-turns-its-focus-overseas-5760857/ 2017-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-orphan-drug-designation-to-boehringer-ingelheims-drug-bi-836858-5760980/ 2017-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsserviers-ucart19-therapy-candidate-gets-investigational-new-drug-clearance-5760981/ 2017-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pharmaceutical-pricing-reform-efforts-in-california-poking-the-bear-in-the-grizzly-state-html/ 2021-11-02T03:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-french-pharmaceutical-market-to-witness-a-negative-compound-annual-growth-rate-of-1-by-2021-5758158/ 2017-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-sichuan-kelun-pharma-ascendis-health-zhuhai-united-labs-5759943/ 2017-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-ataxion-kasten-inc-heat-biologics-inc-5759955/ 2017-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharnext-galapagos-partner-to-generate-new-pipeline-of-synergistic-drug-combinations-5760411/ 2017-03-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbergenbio-merck-to-evaluate-bgb324-with-keytruda-in-nsclc-and-breast-cancer-5760423/ 2022-12-23T09:18:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuniversity-of-sheffield-parkinsons-uk-launch-new-virtual-biotech-company-5759172/ 2017-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsferring-pharmaceuticals-acquires-apricus-ex-us-vitaros-assets-and-rights-5759204/ 2017-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsshares-in-pharmaceutical-and-biotechnology-companies-fall-over-donald-trumps-tweet-5759349/ 2017-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentohr-pharmaceuticals-is-determined-to-show-efficacy-for-squalamine-despite-setbacks-5758316/ 2017-03-08T07:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdespite-widespread-legalisation-federal-regulations-are-keeping-cannabis-research-under-wraps-5758159/ 2017-03-08T06:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmedday-acquires-profilomics-health-division-to-enhance-research-5757985/ 2017-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-for-actelions-ledaga-to-treat-mf-ctcl-5758029/ 2022-12-01T16:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsepo-2016-report-shows-european-patent-filings-in-pharmaceuticals-drop-by-5-5758037/ 2017-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurelearning-from-tragedy-safety-and-dosing-in-first-in-human-trials-5758157/ 2022-07-11T08:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefebruarys-top-stories-takeda-5756905/ 2021-11-22T07:16:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvernalis-and-servier-sign-oncology-drug-discovery-collaboration-5757042/ 2017-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsscotlands-npsc-mrc-sign-mou-to-accelerate-drug-discovery-5757052/ 2017-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvertex-to-acquire-ctp-656-from-concert-pharmaceuticals-5757106/ 2017-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwho-appeal-for-new-antibiotics-lacks-necessary-incentives-5756263/ 2017-03-06T09:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/could-drug-pricing-legislation-be-championed-by-us-president-trump-html/ 2021-11-02T03:27:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureis-us-drug-manufacturing-homeward-bound-5743166/ 2017-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-pasteur-medimmune-to-develop-and-commercialise-medi8897-5755668/ 2017-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-approves-intercepts-ocaliva-for-use-by-nhs-in-uk-5755709/ 2023-05-29T05:33:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-serenitys-noctiva-nasal-spray-for-frequent-nighttime-urination-5755799/ 2017-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpfizer-seeking-a-timely-re-launch-of-mylotarg-in-aml-amid-increasing-competition-5755115/ 2017-03-03T10:15:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportnsclc-incidence-continues-to-increase-in-urban-china-5755110/ 2017-03-03T10:07:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpay-for-performance-deals-for-pharmaceuticals-continue-to-gain-momentum-in-the-us-5755103/ 2017-03-03T09:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportasias-growing-burden-of-an-ageing-population-and-colorectal-cancer-5754871/ 2017-03-03T06:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-japanese-pharmaceutical-market-to-witness-moderate-growth-up-to-2021-5753353/ 2017-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-hybio-pharmaceutical-co-ltd-pfizer-inc-bushu-pharmaceuticals-ltd-5754285/ 2021-10-27T11:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-betta-pharmaceuticals-co-ltd-eli-lilly-and-company-5754287/ 2017-03-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-mercks-erbitux-to-treat-patients-with-metastatic-colorectal-cancer-5754648/ 2022-07-11T08:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmithra-signs-agreement-with-fuji-pharma-to-commercialise-donesta-5754662/ 2021-11-22T13:02:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentrare-diseases-are-a-huge-opportunity-for-pharma-5754076/ 2017-03-02T10:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdisruptive-innovation-in-the-pharmaceutical-industry-bane-or-panacea-5753629/ 2017-03-02T04:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureusing-shark-antibodies-to-treat-alzheimers-disease-5731450/ 2017-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscypralis-to-develop-new-cyclophilin-inhibitors-for-neurodegenerative-diseases-5753330/ 2017-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-xermelo-to-treat-carcinoid-syndrome-diarrhea-5753387/ 2017-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-acquires-colucid-pharmaceuticals-for-960m-5753420/ 2017-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreporttop-selling-cancer-drug-is-under-threat-5752727/ 2017-03-01T09:43:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportvte-too-many-at-risk-patients-are-not-being-treated-5752709/ 2017-03-01T09:10:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-crt-hitgen-to-develop-new-drugs-against-lung-cancer-5752140/ 2017-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-priority-review-for-emd-seronos-application-for-avelumab-5752154/ 2017-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsperrigo-to-sell-tysabri-drug-royalty-to-rpi-for-285bn-5752158/ 2017-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdrivers-for-the-next-decade-of-diabetic-foot-ulcer-drug-sales-5751477/ 2022-11-29T15:54:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportsurge-of-bladder-cancer-in-japan-a-consequence-of-population-aging-5751475/ 2017-02-28T10:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentai-takes-a-hit-while-healthcare-it-continues-to-boom-5751081/ 2017-02-28T05:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentemflaza-launch-in-the-us-on-hold-due-to-pricing-outrage-5751068/ 2017-02-28T05:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwhat-are-the-incentives-and-challenges-to-biosimilar-development-5751024/ 2017-02-28T05:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsclinigen-eisai-partner-to-offer-halaven-for-metastatic-breast-cancer-in-south-africa-5750810/ 2017-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-lonza-to-build-new-270m-mammalian-cell-culture-facility-in-switzerland-5750812/ 2017-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-viekirax-exviera-approved-to-treat-patients-with-genotype-1b-chronic-hepatitis-c-5750824/ 2022-07-11T08:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenta-novel-mosquito-vaccine-promises-broad-protection-but-can-it-deliver-5750261/ 2017-02-27T11:15:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentloosening-fda-approval-standards-would-do-more-harm-than-good-5750238/ 2017-02-27T09:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenta-chemotherapy-free-future-for-breast-cancer-5750237/ 2017-02-27T09:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehow-an-alzheimers-drug-turned-tooth-regenerator-could-unlock-regenerative-medicine-5743123/ 2017-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremoving-mountains-balancing-safety-and-speed-in-drug-development-5744043/ 2017-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaustralian-researchers-initiate-new-non-invasive-urinary-test-to-tackle-mnd-5749243/ 2017-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanten-twoxar-to-identify-new-drug-candidates-for-glaucoma-5749253/ 2021-11-30T12:25:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsantibe-signs-distribution-agreement-with-acbel-for-atb-346-drug-5749358/ 2017-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenta-brighter-future-for-rheumatoid-arthritis-patients-5749117/ 2022-11-29T15:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportbig-data-will-impact-many-pharmaceutical-sectors-over-the-next-five-years-5748943/ 2018-08-06T10:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwill-fda-guidance-on-interchangeability-help-or-hinder-biosimilar-market-growth-5748919/ 2017-02-24T05:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportcan-tanezumab-provide-safer-and-more-effective-treatment-for-cancer-pain-management-5748904/ 2017-02-24T05:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-tauopathies-market-projected-to-grow-with-launch-of-first-to-market-drug-5747562/ 2022-12-23T07:32:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-affigen-llc-albany-molecular-research-inc-bristol-myers-squibb-5748315/ 2017-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-zhejiang-conba-pharmaceutical-co-ltd-biolennia-laboratories-inc-5748353/ 2017-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-awards-orphan-drug-designation-to-minoryxs-min-102-compound-5748808/ 2023-01-04T11:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabivax-to-screen-new-antiviral-molecules-to-develop-therapeutic-candidates-against-dengue-5748878/ 2017-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-regulatory-submission-for-pfizers-inotuzumab-ozogamicin-5746156/ 2017-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnorthwell-health-ge-ventures-collaborate-to-research-on-bioelectronic-medicine-5746417/ 2017-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-and-eyegate-sign-licencing-agreement-5747680/ 2017-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremedicines-discovery-catapult-improving-collaborative-drug-discovery-in-the-uk-5731276/ 2017-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentliquid-biopsies-in-melanoma-transformation-of-patient-care-tantalizingly-close-5746774/ 2023-02-03T08:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportus-to-see-growth-in-diagnosed-prevalence-of-primary-hyperparathyroidism-5746763/ 2017-02-22T10:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-and-tersera-sign-agreement-to-commercialise-zoladex-in-us-and-canada-5745187/ 2017-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-fast-track-designation-for-cell-medicas-cmd-003-5745327/ 2022-12-28T11:57:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsneovacs-and-biosense-sign-agreement-for-development-and-commercialisation-of-ifn-kinoid-in-china-5746084/ 2017-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretherapeutic-orphans-child-friendly-drugs-and-the-quest-for-adherence-5743204/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssobi-renews-ammonul-distribution-agreement-with-valeant-5744875/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrecipharm-acquires-kemwells-pharmaceutical-businesses-in-india-for-1185m-5744909/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmereo-biopharmas-bps-804-drug-accepted-for-participation-in-emas-adaptive-pathways-programme-5744926/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwill-improved-breast-cancer-testing-result-in-better-access-to-ther2-positive-therapy-5745368/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmercks-failure-in-alzheimers-trial-shows-even-earlier-intervention-is-key-5745413/ 2017-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenigerias-hiv-breakthrough-separating-truth-from-hope-5743177/ 2017-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-say-vitamin-b3-prevents-glaucoma-5743923/ 2017-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-and-nhs-ayrshire-arran-launch-new-eye-care-facility-in-scotland-5743936/ 2017-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamygdala-neurosciences-to-acquire-gs-6637-from-gilead-sciences-5743998/ 2017-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsis-digital-disruption-of-heart-disease-markets-on-the-horizon-5743139/ 2017-02-17T09:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdementia-associated-with-soccer-headers-5743135/ 2017-02-17T09:09:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscutting-costs-but-not-quality-heart-failure-hospitalisations-5743129/ 2017-02-17T09:04:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-stada-arzneimittel-neximmune-5741768/ 2021-11-22T07:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-xiangxue-pharmaceutical-co-ltd-auris-medical-holding-ag-enzymatica-ab-5742212/ 2017-02-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalk-receives-acceptance-for-ragweed-sublingual-allergy-immunotherapy-tablet-5742711/ 2023-05-23T03:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvedanta-stanford-and-leiden-universities-partner-to-study-food-allergies-in-children-5742726/ 2017-02-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapans-takeda-acquires-us-cancer-drug-manufacturer-ariad-for-52bn-5742745/ 2017-02-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurea-peptide-to-prevent-pre-diabetes-5731416/ 2017-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamag-pharmaceuticals-signs-us-licence-agreement-for-intrarosa-5741481/ 2017-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmundipharma-helsinn-expand-licensing-distribution-agreements-for-aloxi-and-akynzeo-5741498/ 2017-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-siliq-to-treat-plaque-psoriasis-5741515/ 2017-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-56-5740630/ 2023-04-12T06:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvifor-pharma-gains-commercialisation-rights-for-chemocentryxs-avacopan-in-asia-5740243/ 2017-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsritter-ubc-to-study-role-of-microbiome-and-rp-g28-in-environmental-enteropathy-5740261/ 2017-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-incyte-receive-ecs-marketing-authorisation-approval-for-olumiant-5740281/ 2017-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovimmune-and-legochem-evaluate-antibody-drug-conjugate-candidate-5739231/ 2017-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsipsen-to-acquire-five-consumer-healthcare-products-from-sanofi-5739237/ 2017-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-to-acquire-us-medical-technology-company-zeltiq-for-247bn-5739290/ 2017-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurewhy-the-uk-nhs-needs-clinical-research-5731315/ 2017-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaurobindo-pharma-buys-four-biosimilar-products-from-tl-biopharmaceutical-5738105/ 2021-10-28T07:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-and-pcpa-sign-agreement-for-opdivo-treatment-5738123/ 2017-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-emflaza-tablets-to-treat-patients-with-dmd-5738166/ 2023-05-26T04:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentpharma-marketers-must-embrace-digital-or-be-left-in-the-dark-5737524/ 2017-02-10T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-agro-tek-inc-prometic-life-sciences-inc-nemaura-pharma-ltd-5735462/ 2017-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-global-hepatitis-c-market-to-witness-negative-compound-annual-growth-rate-of-21-by-2025-5735811/ 2017-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-allergan-parexel-international-5736752/ 2017-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnewlink-genetics-selects-cevecs-cap-technologies-to-develop-zika-vaccine-5737103/ 2017-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnatural-cycles-fertility-tracking-app-approved-for-contraception-5737113/ 2017-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentlow-drug-compliance-in-lupus-are-patients-really-to-blame-5736452/ 2022-07-11T08:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-amgens-parsabiv-to-treat-hpt-in-adult-patients-5736070/ 2017-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-awards-grants-for-new-programmes-to-improve-heart-health-5736084/ 2017-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprexton-to-fund-two-phase-ii-studies-of-foliglurax-in-parkinsons-disease-5736108/ 2017-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrenova-takes-over-rights-to-heart-failure-candidate-stresscopin-from-janssen-5734782/ 2017-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswellcome-trust-grants-funding-to-exonate-to-develop-wet-amd-5734808/ 2017-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsespero-acquires-global-rights-to-durlaza-extended-release-capsules-5734834/ 2017-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentmerck-co-weighs-in-on-pharma-pricing-debate-by-releasing-pricing-transparency-report-5733721/ 2017-02-07T05:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-hive-new-incubator-makes-a-beeline-for-non-traditional-pharma-companies-5730514/ 2017-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebenevolentai-using-artificial-intelligence-to-speed-up-drug-discovery-5731295/ 2024-10-07T08:58:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstudy-links-immune-system-genetic-variants-to-development-of-leukaemia-5733606/ 2017-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbelgiums-ablynx-submits-marketing-authorisation-application-for-caplacizumab-approval-5733627/ 2017-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscc-abhi-funds-early-stage-innovations-in-aging-and-brain-health-fields-5733677/ 2017-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejanuarys-top-stories-jj-to-acquire-actelion-for-30bn-takeda-to-acquire-ariad-for-52bn-5730456/ 2017-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswedens-sobi-in-talks-to-sell-its-partner-products-business-area-5732429/ 2017-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscytokinetics-royalty-pharma-sign-agreement-for-omecamtiv-mecarbil-5732446/ 2021-11-25T09:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsparexel-international-to-acquire-us-company-tmac-5732464/ 2017-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportcan-vaccines-treat-colorectal-cancer-effectively-with-no-side-effects-5731343/ 2017-02-03T05:03:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-rigel-pharmaceuticals-inc-vanc-pharmaceuticals-inc-provectus-biopharmaceuticals-inc-5730069/ 2017-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-bristol-myers-squibbs-opdivo-injection-to-treat-muc-5731130/ 2017-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-completes-acquisition-of-lifecell-for-29bn-5731143/ 2017-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspatheon-acquires-roches-manufacturing-facility-in-south-carolina-us-5731194/ 2017-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportimproved-diagnosis-will-increase-number-of-patients-seeking-psoriatic-arthritis-treatment-5730531/ 2017-02-02T10:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportcolorectal-cancer-germany-experiences-a-reversal-of-trends-after-implementing-successful-screening-programs-5730519/ 2017-02-02T09:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentdespite-trumps-surprising-stance-drug-prices-will-continue-to-rise-in-the-us-5730181/ 2017-02-02T05:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-for-msds-keytruda-5730132/ 2017-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-use-big-data-to-map-links-between-cell-shape-and-genes-5730157/ 2017-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-kevzara-antibody-to-treat-patients-with-ra-5730176/ 2017-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commenttrumps-plan-to-move-drug-manufacturing-back-to-the-us-will-take-10-years-5729397/ 2017-10-26T11:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwill-a-focus-on-oncology-bring-blockbuster-success-5729383/ 2017-02-01T10:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsonxeo-institut-curie-to-study-benefits-of-combining-radiotherapy-dna-repair-inhibitors-and-immunotherapy-5728869/ 2017-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvictorian-government-receives-funding-for-thunderstorm-asthma-research-5728897/ 2017-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-wins-court-ruling-for-copaxone-40mgml-patents-5728908/ 2017-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-us-is-lagging-behind-the-uk-and-brazil-in-hiv-treatment-coverage-5728271/ 2017-01-31T11:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentis-big-pharma-in-denial-over-how-to-approach-acute-heart-failure-5728220/ 2017-01-31T09:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwin-for-astrazeneca-as-symbicort-gains-six-months-of-pediatric-exclusivity-in-the-us-5728072/ 2017-01-31T06:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalcmi-and-alcf-partner-with-scancell-to-evaluate-scib2-cancer-vaccine-for-nsclc-treatment-5726829/ 2017-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrealm-therapeutics-submits-ind-application-to-us-fda-for-ad-treatment-5726942/ 2017-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-oxford-university-to-discover-new-approaches-to-treat-type-2-diabetes-5727809/ 2017-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentthe-emergence-of-oncology-biosimilars-5727167/ 2017-01-30T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentwhat-does-brexit-mean-for-medical-regulation-5726893/ 2022-11-16T13:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportwhy-mumps-outbreaks-reoccur-despite-high-vaccination-rates-5726853/ 2017-01-30T06:09:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportincrease-in-atrial-fibrillation-cases-driven-by-growing-and-aging-populations-5726793/ 2017-01-30T05:43:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentis-adhd-an-american-disorder-5726770/ 2017-01-30T05:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentresearch-community-applauds-sepsis-definition-5726688/ 2017-01-30T04:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-nih-begins-funding-programme-to-support-neurological-research-5726698/ 2017-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-uk-project-launched-to-develop-improved-cancer-diagnostic-tests-5726758/ 2017-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-mhra-recommends-roches-new-immunotherapy-atezolizumab-for-bladder-cancer-5726804/ 2017-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/researchreportits-not-just-the-drugs-that-are-improving-5725970/ 2017-01-27T09:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentcdk46-inhibitor-rivalry-in-breast-cancer-begins-5725714/ 2017-01-27T09:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-colorectal-cancers-market-in-eight-major-markets-to-witness-a-cagr-of-3-5722846/ 2017-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-cascadian-therapeutics-inc-ocular-therapeutix-inc-kalytera-therapeutics-inc-5724170/ 2017-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-celgene-intrexon-corporation-5725318/ 2021-11-25T10:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjj-to-acquire-swiss-biotech-company-actelion-for-30bn-5725485/ 2017-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-announces-availability-of-saxadapa-fdc-in-uk-5725499/ 2017-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvies-maa-validated-by-ema-for-pan-genotypic-regimen-of-gp-5724460/ 2017-01-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbiocon-malaysia-to-supply-rh-insulin-formulations-5724478/ 2017-01-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-genentech-actemras-sbla-for-giant-cell-arteritis-5724196/ 2017-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbedrocan-recognised-as-worlds-first-gmp-approved-medicinal-cannabis-producer-5724215/ 2017-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerus-closes-global-strategic-research-collaboration-with-incyte-5724223/ 2017-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentbms-will-have-their-cake-and-eat-it-with-keytruda-settlement-5723066/ 2017-01-24T04:54:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/comparing-health-outcomes-and-pharma-pricing-around-the-world-a-pisa-for-healthcare-is-a-health-ministers-worst-nightmare-html/ 2021-11-02T03:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinnovate-uk-grants-funding-to-cypralis-to-develop-cyclophilin-d-inhibitors-5722948/ 2023-01-04T11:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-reveals-caspase-2-enzyme-deficiency-increases-risk-of-developing-tumours-5722971/ 2017-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-sciences-maa-for-chronic-hepatitis-c-therapy-validated-in-europe-5722995/ 2017-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentnew-fda-guidelines-aim-to-mitigate-development-of-antibiotic-resistance-5722233/ 2017-01-23T09:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretapping-the-internet-to-improve-drug-adherence-5711300/ 2017-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscanadas-abcellera-gets-grant-from-gates-foundation-to-help-fight-tuberculosis-5721660/ 2017-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-abbvies-imbruvica-to-treat-marginal-zone-lymphoma-5721669/ 2017-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-agrees-to-resolve-keytruda-patent-infringement-litigation-5721689/ 2017-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretakeda-and-ovid-to-co-develop-drug-for-rare-pediatric-epilepsies-5721027/ 2017-01-20T06:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-us-pharmaceutical-market-projected-to-grow-at-a-cagr-of-44-up-to-2020-5720032/ 2017-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-to-acquire-us-company-colucid-pharmaceuticals-for-960m-5720828/ 2017-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaustralias-telix-completes-product-collaboration-agreement-with-atlab-pharma-5720843/ 2017-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-bio-rad-labs-eli-lilly-5720955/ 2017-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-shenzhen-kangtai-biological-products-co-ltd-telix-pharmaceuticals-limited-fresenius-finance-ireland-plc-5720964/ 2021-11-22T07:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-changing-nsclc-subtypes-cancer-associated-with-non-smokers-in-the-lead-5720458/ 2017-01-19T09:13:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuspto-issues-notice-of-allowance-for-mithras-application-for-estetrol-patent-5720006/ 2017-01-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswedens-amra-gets-funding-to-redefine-obesity-and-support-clinical-trials-5720018/ 2022-07-11T08:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-researchers-find-new-method-to-protect-pancreas-from-digestive-enzymes-5720257/ 2023-02-27T05:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-55-5719431/ 2023-04-12T06:22:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmalecare-launches-new-mobile-application-cancergraph-to-track-cancer-symptoms-5719000/ 2017-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-acquires-manufacturing-rights-for-api-from-roche-to-treat-insomnia-5719024/ 2017-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-crt-and-mrc-to-target-cancer-immunotherapies-5719058/ 2017-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-study-finds-benzodiazepines-usage-increases-stroke-risks-in-people-with-alzheimers-disease-5716858/ 2017-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-amends-marketing-authorisation-for-pharmings-ruconest-to-include-self-administration-5718057/ 2023-05-09T07:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmc-rejects-two-indications-of-myeloma-drugs-kyprolis-and-darzalex-in-scotland-5718068/ 2017-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentroches-tecentriq-pulls-further-ahead-of-rivals-in-metastatic-bladder-cancer-5717008/ 2017-01-16T04:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-payments-to-doctors-seeking-transparency-5711295/ 2017-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-extends-review-period-for-eli-lilly-and-incytes-rheumatoid-arthritis-treatment-5716742/ 2017-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsm-pharmaceutical-to-develop-new-topical-drug-product-for-fsd-5717080/ 2023-01-19T07:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-to-leverage-palantirs-data-analytics-capabilities-5717200/ 2017-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-macrophage-pharma-bioleaders-corbin-therapeutics-5715076/ 2017-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-dendreon-pharmaceuticals-inc-agile-pharma-bv-takeda-pharmaceutical-company-limited-5715380/ 2017-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsorthocell-collaborates-with-jjs-depuy-synthes-for-ortho-ati-approach-5716238/ 2017-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-mylans-bla-for-proposed-trastuzumab-product-5716282/ 2017-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-fast-track-designation-for-starpharmas-vivagel-bv-treatment-5716295/ 2023-01-04T11:40:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-scientists-discover-new-chemical-inhibitor-of-cancer-stress-signal-5715223/ 2017-01-12T16:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurehow-does-the-nhs-weigh-the-costs-of-hiv-preventing-drugs-5007956/ 2017-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-finds-antidepressant-use-increases-hip-fracture-risk-in-people-with-alzheimers-disease-5715235/ 2017-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspitt-bayer-to-advance-research-for-heart-lung-and-blood-disease-indications-5715270/ 2017-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureafter-the-cure-addressing-side-effects-in-childhood-cancer-patients-5711091/ 2023-01-24T15:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-to-sell-dendreon-to-chinas-sanpower-for-8199m-5714173/ 2017-01-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-ratifies-positive-opinion-for-ptcs-translarna-marketing-authorisation-renewal-5714191/ 2017-01-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszambon-seqirus-partner-for-parkinsons-disease-product-in-australia-and-new-zealand-5714202/ 2017-01-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-roches-supplemental-biologics-license-application-5712968/ 2017-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsipsen-to-acquire-global-oncology-assets-from-merrimack-for-1025bn-5713003/ 2017-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjapans-takeda-to-acquire-us-cancer-drug-manufacturer-ariad-for-52bn-5713089/ 2017-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureindias-drug-price-overhaul-a-question-of-balance-5711341/ 2017-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerus-and-irb-to-develop-novel-agents-to-target-tumour-microenvironment-5711958/ 2022-02-14T11:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaurobindo-pharma-to-acquire-generis-for-135m-5711965/ 2017-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabcellera-to-discover-antibodies-against-membrane-protein-targets-using-mab-platform-5711984/ 2017-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-sucampo-pharmaceuticals-satsuma-pharmaceuticals-nanjing-hicin-pharmaceutical-co-ltd-5710613/ 2017-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-northern-biologics-sumitomo-dainippon-pharma-co-ltd-premaitha-health-plc-5710620/ 2021-11-23T04:01:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-dyslipidemia-market-projected-to-reach-292bn-by-2025-5710785/ 2017-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearch-finds-how-cancer-cells-break-free-physical-restraints-to-grow-and-spread-5710968/ 2017-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-trial-successfully-blocks-epo-signalling-to-improve-cord-blood-transplant-process-5710991/ 2017-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportthe-first-follow-on-biologic-insulin-is-launched-in-the-us-5710019/ 2017-01-05T08:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportdavid-takes-on-goliath-abbvie-to-disrupt-gileads-dominance-5710014/ 2017-01-05T05:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/hurdles-encountered-in-transferability-of-health-economic-evidence-to-middle-and-low-income-countries-html/ 2021-11-02T03:27:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-sobis-orfadin-capsules-to-treat-ht-1-5709954/ 2017-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprokarium-and-probiomed-to-manufacture-orally-administered-vaccines-for-diarrhoea-5709964/ 2017-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssynpromics-and-ge-healthcare-to-develop-synthetic-promoters-5710028/ 2017-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsredhill-and-concordia-sign-co-promotion-agreement-for-donnatal-drug-promotion-5709089/ 2017-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisais-fycompa-licenced-for-treatment-of-partial-onset-seizures-5709115/ 2017-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-pasteur-ends-vaccine-jv-with-msd-5709132/ 2017-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepay-for-delay-how-far-will-companies-go-to-protect-market-exclusivity-5693101/ 2017-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature2016-the-years-biggest-pharmaceutical-technology-stories-5705544/ 2017-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-launches-new-adhd-treatment-in-us-5707957/ 2017-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinnocolls-xaracoll-receives-refusal-to-file-letter-from-fda-5707966/ 2017-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmoberg-pharma-acquires-dermoplast-from-prestige-brands-5708505/ 2017-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/two-sides-of-the-same-coin-national-health-economic-guidelines-in-italy-and-portugal-html/ 2021-11-02T03:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsseasons-greetings-pharma-2016-5703487/ 2016-12-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-number-of-blockbuster-drugs-dropped-in-2016-despite-high-rd-costs-5703590/ 2016-12-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsallergan-to-acquire-acelitys-regenerative-medicine-unit-lifecell-for-29bn-5703732/ 2016-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfluor-wins-contract-for-novo-nordisks-2bn-diabetes-api-facility-in-us-5703746/ 2016-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-to-acquire-us-company-encore-vision-5703761/ 2021-12-01T12:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-approves-expanded-indication-for-pfizers-nimenrix-vaccine-to-treat-imd-5702700/ 2016-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-rubraca-to-treat-advanced-ovarian-cancer-5702716/ 2016-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-submits-nda-to-us-fda-for-pan-genotypic-regimen-of-gp-5702731/ 2016-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmylan-launches-authorised-generic-version-of-epipen-5701536/ 2016-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsip-group-announces-creation-of-sanger-institute-uk-spin-out-company-microbiotica-5701551/ 2016-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-approves-msds-pd-1-therapy-keytruda-to-treat-patients-with-nsclc-5701569/ 2023-01-24T15:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscma-accuses-actavis-uk-of-overcharging-nhs-for-hydrocortisone-tablets-5700255/ 2016-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-researchers-say-saliva-testing-could-form-new-tool-to-assess-immunity-5700288/ 2016-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdomain-therapeutics-signs-gpcr-licensing-agreement-with-alkermes-5700304/ 2021-12-01T13:20:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-qgel-cytrx-bod-australia-5697589/ 2016-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-pfizer-inc-kdb-capital-corp-5697596/ 2016-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-opens-new-global-vaccines-rd-centre-in-us-5699271/ 2016-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-domainex-invests-in-new-microscale-thermophoresis-technology-5699274/ 2016-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-eucrisa-ointment-to-treat-eczema-5699292/ 2016-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsab-initio-and-pfizer-partner-to-discover-gpcr-activating-antibodies-5697993/ 2016-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscdc-study-reveals-zika-virus-replicates-in-foetal-brain-and-placentas-5698022/ 2016-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsferrings-rekovelle-gets-marketing-authorisation-from-ec-5698047/ 2016-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-54-5697084/ 2023-04-21T09:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredebating-the-value-of-targeted-lung-cancer-treatments-5677546/ 2016-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofis-jevtana-drug-receives-smc-approval-to-treat-prostate-cancer-5696710/ 2016-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-research-groups-partner-to-develop-new-vaccine-against-zika-virus-5696724/ 2016-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsherantis-pharma-gets-eu-horizon-2020-programme-grant-for-parkinson-study-5696742/ 2016-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstrides-shasun-to-acquire-perrigo-api-india-5695352/ 2021-11-22T09:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-launches-new-sms-for-life-20-healthcare-programme-in-nigeria-5695364/ 2016-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgrnenthal-signs-agreement-with-astellas-for-dermal-patch-qutenza-rights-5695380/ 2016-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuregenomic-array-could-unlock-war-against-diseases-in-africa-5692064/ 2016-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-and-lilly-partner-to-co-develop-alzheimers-disease-treatment-5694181/ 2016-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-sanofi-and-regenerons-maa-for-dupixent-5694199/ 2016-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuks-crt-pioneer-fund-to-invest-in-new-blood-cancer-drug-5694213/ 2016-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretackling-false-trial-data-in-china-5691656/ 2023-01-24T15:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-ribomic-inc-puridify-limited-ferring-pharmaceuticals-5691270/ 2021-11-25T11:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-teledyne-technologies-incorporated-addlife-ab-5691288/ 2021-12-07T04:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-global-neurodegenerative-disorders-market-to-reach-45bn-by-2022-5692513/ 2016-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-researchers-find-safety-catch-in-cell-division-machinery-5692895/ 2016-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharming-acquires-north-american-commercialisation-rights-for-ruconest-5692920/ 2023-05-09T07:24:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureibuprofen-could-this-ubiquitous-drug-be-entering-a-whole-new-era-5688738/ 2016-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibbs-opdivo-approved-to-treat-blood-cancer-in-eu-5689641/ 2016-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssri-wins-150m-contract-to-accelerate-production-of-hiv-prevention-products-5691477/ 2016-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschemotherapy-drug-combination-may-cause-women-to-grow-new-eggs-finds-study-5691663/ 2016-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbvie-partners-with-johns-hopkins-university-for-cancer-research-5689632/ 2016-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenovembers-top-stories-patheon-to-buy-api-facility-uk-nice-approves-celgenes-drug-5689815/ 2016-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuks-cma-fines-pfizer-flynn-pharma-nearly-90m-for-unfair-pricing-of-epilepsy-drug-5690357/ 2016-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbtg-launches-dc-bead-lumi-for-liver-cancer-patients-in-canada-5688409/ 2023-01-24T15:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-myeloma-genome-project-established-to-advance-diagnosis-and-treatments-5687673/ 2016-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovimmune-genentech-enter-exclusive-licence-agreement-for-rheumatoid-arthritis-drug-5688327/ 2016-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmelbourne-scientists-develop-first-therapeutic-dental-vaccine-5688342/ 2023-05-19T04:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentkeytruda-data-add-fuel-to-debate-over-pd-l1-as-a-biomarker-in-metastatic-bladder-cancer-5687628/ 2016-12-05T05:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepfizers-big-antibiotic-buyout-a-sign-of-things-to-come-5677454/ 2016-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-finalises-agreement-with-brazilian-moh-for-tivicay-supply-5687315/ 2016-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseib-to-support-amryt-pharmas-new-treatment-for-skin-disorders-5687329/ 2022-12-07T14:07:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-scientists-create-map-of-licensed-drugs-to-search-for-future-treatments-5687333/ 2016-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-genetic-analysis-boehringer-ingelheim-gmbh-vigene-biosciences-inc-5684963/ 2016-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-thermo-fisher-scientific-heptares-therapeutics-5684978/ 2016-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-israeli-pharmaceutical-market-to-grow-at-a-compound-annual-growth-rate-of-39-5685762/ 2016-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-to-invest-226m-in-cancer-research-5686114/ 2016-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-gsks-new-injectable-asthma-drug-nucala-5686140/ 2016-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureketamine-taking-aim-at-depression-5676318/ 2016-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-says-stroke-patients-in-uk-can-benefit-from-new-treatment-5684817/ 2016-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-to-invest-100m-in-manufacturing-plant-for-dengue-vaccine-in-germany-5684828/ 2016-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrwanda-becomes-third-country-to-launch-novartis-access-programme-5684845/ 2016-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoxford-biomedica-orchard-therapeutics-to-develop-ex-vivo-gene-therapy-products-5683719/ 2016-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswedens-pharmalink-obtains-omp-designation-for-nefecon-5683736/ 2016-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspatheon-to-acquire-new-api-manufacturing-facility-in-us-from-roche-5683748/ 2016-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjj-in-talks-to-acquire-swiss-drugmaker-actelion-5682568/ 2016-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-nice-recommends-janssens-imbruvica-as-treatment-for-adults-with-cll-5682585/ 2023-01-17T10:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-drops-400m-expansion-plans-of-grange-castle-plant-in-ireland-5682602/ 2016-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-research-finds-38-of-uk-parents-wrongly-think-rash-as-meningitis-first-symptom-5681241/ 2023-03-31T10:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-for-takedas-ninlaro-capsules-5681249/ 2016-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsarrow-generiques-signs-agreement-to-purchase-selects-assets-in-france-from-teva-5681467/ 2016-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-laboratorios-farmaceuticos-rovi-proteros-biostructures-gmbh-bionor-pharma-5678468/ 2016-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-sun-pharmaceuticals-allergan-plc-5678475/ 2016-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-non-small-cell-lung-cancer-market-to-reach-20bn-by-2025-5678929/ 2016-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-identifies-mechanism-for-genetic-risk-of-developing-myeloma-5679974/ 2016-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsneovacs-and-3p-biopharmaceuticals-partner-to-manufacture-ifn-5679982/ 2016-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-acquires-chase-pharmaceuticals-for-125m-5678649/ 2016-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-nice-approves-celgenes-imnovid-drug-for-use-in-relapsed-myeloma-patients-5678671/ 2016-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-commission-approves-bristol-myers-squibbs-opdivo-inhibitor-5678693/ 2016-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswest-ward-pharmaceuticals-and-vectura-to-develop-generic-salmeterol-product-5677146/ 2016-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssingapore-researchers-artificially-generate-mouse-blood-from-skin-cells-5677165/ 2016-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsproteros-and-merck-sign-new-research-agreement-on-epigenetic-target-5677182/ 2016-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-gets-european-commission-approval-for-trisenox-indication-extension-5675797/ 2016-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-files-regulatory-submission-with-us-fda-for-ffumecvi-therapy-5675806/ 2021-11-22T07:20:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-acquires-selexys-pharmaceuticals-in-us-for-665m-5675813/ 2016-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-medimmune-completes-licensing-agreement-with-allergan-for-medi2070-5674429/ 2016-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsrussian-federation-set-to-introduce-new-scientific-drug-research-projects-5674454/ 2016-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-approves-intrarosa-to-treat-dyspareunia-5674475/ 2016-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/big-dreams-versus-cost-saving-schemes-will-the-uk-dare-to-pursue-its-accelerated-access-ambitions-in-cash-strapped-times-html/ 2021-11-02T03:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-dna-link-proteomics-international-laboratories-kamada-ltd-5671375/ 2016-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-mettrum-health-corp-tonghua-golden-horse-pharmaceutical-industry-jafron-biomedical-5671398/ 2021-12-03T10:25:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-myelofibrosis-market-to-grow-at-the-compound-annual-growth-rate-of-64-by-2025-5671509/ 2016-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoxford-researchers-work-on-two-eu-funded-projects-to-deliver-new-antibiotic-programme-5672840/ 2016-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-finds-modified-virus-could-stimulate-immune-attack-on-liver-cancer-cells-5672879/ 2016-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-53-5672142/ 2023-04-12T06:35:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-and-enterome-sign-immuno-oncology-agreement-5671604/ 2016-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-allergan-submit-biologics-license-application-to-us-fda-for-abp-215-5671628/ 2016-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebernie-vs-big-pharma-5672068/ 2016-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswiss-company-roche-unveils-global-cancer-immunotherapy-research-network-5671571/ 2016-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbasilea-pharmaceutica-launches-antifungal-medication-cresemba-in-france-5670305/ 2023-05-30T04:20:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-and-nci-to-evaluate-three-investigational-immunotherapy-agents-5670323/ 2016-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-zealands-upside-biotechnologies-launches-new-skin-replacement-treatment-5670343/ 2016-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-finds-74-of-uk-public-support-test-before-antibiotic-prescriptions-5667480/ 2016-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvictoria-announces-10m-grant-to-aid-cancer-researchers-5668574/ 2016-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-priority-review-to-novartis-leukaemia-drug-5669307/ 2016-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-access-to-medicine-index-2016-highlighting-the-role-for-tiered-pricing-html/ 2021-11-02T03:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseli-lilly-secures-conditional-marketing-authorisation-for-olaratumab-injection-with-doxorubicin-5666279/ 2016-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsstudy-reveals-synthetic-dna-vaccine-approach-successfully-protects-against-zika-virus-5666641/ 2016-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsibm-watson-broad-institute-to-research-on-drug-resistant-cancer-5666681/ 2016-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/trumping-obamacare-may-be-on-the-cards-html/ 2021-11-02T03:27:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-novel-pipeline-products-to-drive-schizophrenia-market-growth-5664345/ 2016-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-incyte-corporation-orexigen-therapeutics-ireland-ltd-mitsubishi-tanabe-pharma-corporation-5664650/ 2016-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-citoxlab-sichuan-kelun-pharma-5664802/ 2016-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinvestigational-hiv-therapeutic-vaccine-found-to-control-siv-in-preclinical-studies-5665316/ 2016-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsresearchers-develop-screening-test-to-identify-therapies-against-drug-resistant-bacteria-5665368/ 2016-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbenevolentai-signs-exclusive-license-agreement-with-janssen-for-clinical-stage-drugs-5663207/ 2016-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsscintilla-pharmaceuticals-completes-acquisition-of-majority-share-in-scilex-5663454/ 2016-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshaiti-launches-cholera-vaccination-campaign-5663792/ 2016-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureoctobers-top-stories-gsk-shingles-vaccine-pfizers-inflectra-injection-in-us-5665530/ 2023-01-19T06:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuniversity-of-adelaide-researchers-test-drug-that-promises-to-prevent-pre-term-birth-5662192/ 2016-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-receives-approval-for-generic-tribenzor-in-us-5662231/ 2016-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/the-other-vote-today-will-the-future-of-us-drug-pricing-be-decided-will-we-see-interstate-parallel-imports-and-interstate-reference-pricing-html/ 2021-11-02T03:27:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-cancer-research-technology-collaborate-with-tyg-oncology-5660657/ 2016-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmodus-therapeutics-secures-two-patents-in-us-for-sevuparin-to-treat-sickle-cell-disease-5660679/ 2016-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureantibiotic-resistance-the-race-for-the-prize-5662608/ 2016-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-accepts-review-of-mylans-maa-for-insulin-glargine-to-treat-diabetes-5659139/ 2016-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmhra-grants-patients-in-us-with-one-form-of-blood-cancer-access-to-investigational-medicine-5659206/ 2016-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-recommends-treatment-with-ticagrelor-60mg-in-post-heart-attack-patients-5659217/ 2023-01-24T15:29:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-asymchem-laboratories-xbrane-biopharma-ab-biohaven-pharmaceutical-holding-company-5656961/ 2021-11-26T05:31:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-canopy-growth-corporation-novogen-limited-karo-pharma-ab-5656965/ 2016-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslonza-opens-drug-product-services-laboratory-in-switzerland-5657142/ 2016-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsge-healthcare-and-valneva-collaboration-results-in-cell-culture-medium-for-vaccine-production-5657583/ 2016-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-and-american-cancer-society-release-report-on-cancer-death-in-women-5655251/ 2016-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaleant-reportedly-in-talks-to-divest-gastrointestinal-treatment-specialist-business-5655674/ 2016-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-team-of-health-experts-to-help-control-global-disease-outbreaks-5655981/ 2016-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureopen-debate-is-it-ever-justified-to-withhold-clinical-trial-data-5027386/ 2023-01-24T15:28:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmedivir-to-sell-biophausia-to-karo-pharma-5654468/ 2021-11-22T06:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-lee011-receives-fda-priority-review-for-first-line-treatment-of-hrher2-advanced-breast-cancer-5654489/ 2016-11-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/where-there-isnt-a-will-there-isnt-a-way-obstacles-to-differential-pricing-html/ 2021-11-02T03:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-validates-maa-for-avelumab-for-treatment-of-metastatic-merkel-cell-carcinoma-5653213/ 2023-02-03T08:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastellas-to-acquire-german-company-ganymed-pharmaceuticals-for-12bn-5654353/ 2016-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergen-to-acquire-motus-therapeutics-5652143/ 2023-01-25T11:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsopiant-pharmaceuticals-obtains-development-and-commercialisation-rights-for-heroin-vaccine-5652146/ 2016-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsswissmedic-approves-sobis-alprolix-to-treat-haemophilia-b-5652827/ 2016-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/proposed-hta-agency-agnets-the-creation-of-a-fourth-hurdle-in-argentina-html/ 2021-11-02T03:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-nordic-nanovector-myriad-rbm-relief-therapeutics-sa-5650140/ 2016-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-evotec-ag-shandong-jincheng-pharmaceutical-irom-group-5650154/ 2021-11-22T09:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/researchreportreport-quadrivalent-vaccines-and-rising-immunisation-recommendations-to-drive-growth-of-seasonal-influenza-vaccines-5650425/ 2016-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsisraels-teva-pharmaceutical-and-ibm-expand-global-e-health-alliance-5651369/ 2016-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-fiocruz-and-wrair-partner-to-conduct-research-on-zika-vaccine-5651378/ 2016-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsall-nhs-trusts-offer-research-to-patients-5648760/ 2016-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-fimbrion-partner-to-develop-molecule-drug-for-utis-5649899/ 2016-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshealth-canada-approves-shires-vyvanse-for-binge-eating-disorder-treatment-5649916/ 2022-12-07T14:02:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredeveloping-new-drugs-for-tourette-syndrome-5649137/ 2023-02-16T05:13:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/through-the-comparative-effectiveness-research-lens-us-european-payers-have-a-taste-for-real-world-trials-html/ 2021-11-02T03:27:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-study-reveals-75-of-critically-ill-patients-in-latin-america-are-malnourished-5647374/ 2016-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsheat-biologics-university-of-miami-to-develop-gp96-based-zika-vaccine-5648260/ 2016-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-submits-biologics-license-application-to-fda-for-shingles-vaccine-5645960/ 2016-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-snda-for-xtandi-in-advanced-prostate-cancer-5646252/ 2016-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureplague-flu-and-zika-could-2017-bring-vaccines-for-all-three-5646416/ 2023-05-19T04:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsicgeb-sun-pharma-partner-to-develop-new-vaccine-for-dengue-5039267/ 2016-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshmt-to-support-nias-study-on-brain-metabolomic-profiles-in-alzheimers-5645623/ 2016-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-researchers-explore-using-nanotechnology-to-improve-hiv-drug-therapies-5645641/ 2016-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-colombian-pharmaceutical-market-to-grow-at-a-cagr-of-73-5037787/ 2016-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-accurexa-perlara-pbc-myovant-sciences-ltd-5037850/ 2016-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-chengdu-kanghong-pharmaceutical-group-cachet-pharmaceutical-co-ltd-antegrin-therapeutics-indalo-therapeutics-5038976/ 2021-11-23T04:01:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscanadas-domain-therapeutics-creates-new-company-to-stop-progression-of-parkinsons-disease-5039298/ 2016-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newselsevier-selects-four-start-up-companies-for-the-hive-incubator-project-5039363/ 2016-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-52-5038098/ 2023-04-12T06:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecould-activating-telomerase-trick-the-ageing-process-5027378/ 2023-01-19T06:39:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-awards-21-new-clinical-trial-research-grants-5037729/ 2016-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-orphan-designation-for-actinium-pharmaceuticals-iomab-b-drug-in-eu-5037755/ 2016-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspine-biotech-medexprim-selected-as-grand-prize-winners-of-2016-presidents-startup-challenge-5037904/ 2016-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsacura-to-provide-aversion-technology-to-kempharm-5036217/ 2016-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-introduce-inflectra-in-us-5036228/ 2016-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebringing-together-oxford-and-cambridges-biopharma-clusters-5026979/ 2016-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsferrings-rekovelle-receives-positive-opinion-from-chmp-5034269/ 2016-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsapitope-regains-global-rights-to-atx-ms-1467-compound-5034291/ 2016-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsworld-anti-doping-agency-astellas-pharma-collaborate-to-prevent-misuse-and-abuse-of-medicines-5032323/ 2016-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdaiichi-sankyo-and-dana-farber-cancer-institute-partner-for-lung-cancer-research-5032744/ 2016-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-receives-positive-opinion-from-emas-chmp-to-extend-indication-of-trisenox-for-apl-treatment-5033685/ 2016-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-medical-tourism-to-drive-growth-of-the-uae-pharmaceutical-market-by-double-digit-5028803/ 2022-07-20T04:44:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-heat-biologics-celsion-corporation-cambridge-isotope-laboratories-5030275/ 2021-11-22T09:51:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsocular-and-regeneron-to-develop-sustained-release-formulation-of-aflibercept-5031916/ 2016-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-pieriandx-danaher-corporation-5031948/ 2016-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergans-belkyra-medicine-receives-swedish-approval-to-treat-double-chin-5031952/ 2016-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaetna-merck-partner-to-provide-better-access-to-type-2-diabetes-treatment-5030571/ 2016-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsisraels-teva-launches-new-generic-oral-contraceptive-in-us-5030676/ 2016-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-researchers-to-develop-new-treatment-for-type-1-diabetes-5030691/ 2016-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureback-to-biology-how-berg-is-using-artificial-intelligence-to-tackle-cancer-5026285/ 2016-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnational-multiple-sclerosis-society-in-us-to-support-42-new-research-projects-5029171/ 2016-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscharles-river-extends-drug-discovery-alliance-with-roches-genentech-5029185/ 2016-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsacccs-investigation-finds-gsks-statements-on-panadol-osteo-price-increase-were-ambiguous-5028316/ 2016-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspiramal-to-acquire-anesthesia-injectable-products-from-janssen-for-155m-5028319/ 2016-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswuxi-apptec-opens-third-facility-in-us-5027231/ 2016-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszeria-pharmaceutical-receives-approval-in-japan-for-zentacort-capsules-5027435/ 2021-11-22T09:14:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-secures-contract-from-barda-5027437/ 2016-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-emerging-economies-to-take-over-the-us-in-the-global-generics-market-5023662/ 2016-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureseptembers-top-stories-us-researchers-to-develop-epilepsy-drugs-ges-150m-biopharmaceutical-campus-5024829/ 2016-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-riptide-bioscience-turning-pharmaceuticals-aralez-pharmaceuticals-5025500/ 2023-04-06T10:23:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-find-biological-evidence-linking-zika-infection-with-guillain-barr-syndrome-5026572/ 2016-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-agrees-to-sell-actavis-generics-assets-and-operations-in-uk-ireland-to-accord-healthcare-5026587/ 2016-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-alliqua-biomedical-integumen-limited-5027022/ 2016-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbarda-awards-contract-to-newlink-genetics-for-ebola-vaccine-development-5023577/ 2016-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseusa-pharma-obtains-global-rights-of-isqette-from-apeiron-biologics-5023811/ 2016-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmilo-biotechnology-receives-orphan-drug-designation-for-aav1-fs344-to-treat-inclusion-body-myositis-5025374/ 2023-01-04T11:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentelagolix-launch-is-welcome-but-it-wont-be-a-cure-all-for-endometriosis-5687550/ 2023-06-15T04:09:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-launches-uritos-tablets-to-treat-overactive-bladder-in-thailand-5023272/ 2023-01-19T06:36:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-completes-500m-acquisition-of-allergans-anda-5023279/ 2016-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureibms-lab-on-a-chip-breakthrough-seeks-out-cancers-origin-5014330/ 2016-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-grants-breakthrough-therapy-designation-to-abbvies-gp-to-treat-hcv-5021134/ 2016-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-signs-licensing-agreement-with-medimmune-for-medi2070-5021136/ 2016-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinfirsts-granulox-available-for-chronic-wounds-in-nhs-uk-5021269/ 2023-05-23T04:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-3d-printed-human-torso-could-transform-radiotherapy-development-5021415/ 2016-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-research-uk-msd-verastem-to-trial-new-combination-of-immunotherapy-drugs-5021433/ 2016-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-malaysian-pharmaceutical-market-to-grow-at-a-cagr-of-95-by-2020-5018511/ 2016-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-selects-delsitech-as-technology-partner-for-ophthalmology-drug-delivery-5018714/ 2016-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-athenex-papgene-inc-ironwood-pharmaceuticals-5019123/ 2016-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-cambrex-corporation-sichuan-kelun-pharmaceutical-5019136/ 2016-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshanmi-roches-genentech-to-develop-and-commercialise-pan-raf-inhibitor-hm95573-5020283/ 2021-11-22T07:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-to-sell-remaining-stake-in-south-african-drugmaker-aspen-5018694/ 2016-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newskenya-launches-worlds-first-child-friendly-tb-medicines-5018814/ 2016-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuks-nice-recommends-bayers-eylea-for-adults-with-visual-impairment-5018938/ 2016-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-fda-establish-new-cluster-to-support-medicine-development-for-rare-diseases-5016252/ 2016-09-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsassistrx-and-newcrop-to-improve-capabilities-for-electronic-health-records-5017865/ 2022-09-27T11:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspharmaron-to-acquire-merck-sharpe-dohmes-hoddesdon-research-facility-in-uk-5015533/ 2016-09-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsparexel-enters-into-definitive-agreement-to-acquire-execupharm-5016057/ 2016-09-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallele-gets-nih-grant-to-develop-new-antibody-therapy-for-alzheimers-disease-5014276/ 2016-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-grants-approval-for-novartis-ilaris-to-treat-periodic-fever-syndromes-5014453/ 2016-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-accepts-sanofi-and-regenerons-dupilumab-bla-for-priority-review-5014786/ 2016-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-bayer-ag-plasticell-ltd-sarepta-therapeutics-5012788/ 2021-11-22T12:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-allergan-plc-walvax-biotechnology-co-ltd-5012800/ 2021-12-01T10:23:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-favourable-market-environment-to-drive-australian-pharmaceutical-industry-to-25bn-by-2020-5013520/ 2016-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanaria-receives-fda-fast-track-designation-for-malaria-vaccine-5013901/ 2016-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsec-grants-marketing-authorisation-for-allergans-truberzi-to-treat-ibs-d-5013913/ 2016-09-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-51-5012919/ 2023-04-12T06:17:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureus-precision-medicine-initiative-gears-up-for-a-massive-e-health-drive-5001799/ 2016-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrt-sv-life-sciences-set-up-artios-pharma-to-develop-drugs-targeting-dna-damage-response-in-cancer-5011680/ 2016-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-janssens-invokamet-xr-for-type-2-diabetes-treatment-in-adults-5012445/ 2016-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-confirms-safety-of-plasma-and-urine-derived-medicines-from-zika-virus-contamination-5012560/ 2016-09-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmajor-pharmaceutical-companies-present-new-roadmap-to-combat-antimicrobial-resistance-5011294/ 2016-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiontech-genentech-partner-to-develop-individualised-mrna-cancer-therapies-5011387/ 2016-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuregoing-global-indias-big-biosimilar-move-5001775/ 2021-10-29T05:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssarepta-therapeutics-gets-fda-approval-for-exondys-51-to-treat-dmd-5009771/ 2016-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newszydus-cadila-and-takeda-partner-to-develop-vaccine-for-chikungunya-virus-5010031/ 2016-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsema-grants-positive-opinion-for-takedas-ninlaro-to-treat-multiple-myeloma-in-adult-patients-5008378/ 2016-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsge-to-invest-150m-to-build-biopharmaceutical-manufacturing-campus-in-ireland-5008523/ 2016-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscesca-therapeutics-receives-two-patents-for-rapid-infusion-of-autologous-bone-marrow-derived-stem-cells-5009247/ 2023-03-01T08:58:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdeals-this-week-morphotek-pra-health-sciences-agios-pharmaceuticals-5006053/ 2016-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmas-this-week-duran-group-gmbh-catalent-pharma-solutions-5006061/ 2016-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-asia-pacific-gastric-cancer-market-to-grow-to-27bn-by-2022-but-prospects-weak-for-premium-pricing-5006757/ 2016-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsontario-provides-shingles-vaccine-to-senior-citizens-for-free-5007323/ 2016-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-shires-cuvitru-treatment-in-adult-and-paediatric-patients-5007632/ 2016-09-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureis-the-stage-set-for-global-drug-price-regulation-5001432/ 2016-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallergan-signs-agreement-to-acquire-vitae-pharmaceuticals-for-639m-5006600/ 2016-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-launches-moodivator-app-to-help-treat-depression-5006631/ 2016-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscollection-of-nearly-50-de-prioritised-pharma-compounds-available-to-researchers-5006767/ 2016-09-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/japan-hints-at-potential-exodus-of-pharmaceutical-companies-from-post-brexit-london-html/ 2021-11-02T03:27:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssingapore-researchers-develop-new-protein-to-alter-dna-in-living-cells-5005210/ 2016-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbrainvectis-gets-funding-to-support-its-gene-therapy-for-huntingtons-and-alzheimers-disease-5005400/ 2016-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/commentrule-breakers-rehabilitating-wayward-researchers-5000522/ 2016-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjj-submits-its-ebola-vaccine-regimen-to-who-for-eual-5003792/ 2016-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglaxosmithkline-sells-non-core-assets-to-aspen-5003866/ 2016-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskymab-tests-first-step-in-new-approach-to-develop-human-vaccine-against-hiv-5002708/ 2016-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmdi-signs-distribution-licensing-agreement-for-penthrox-inhaler-in-canada-5002712/ 2016-09-11T17:30:00+00:00 daily 0.2